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INTRODUCTION 
Introduction of a vast number of biomolecules with high therapeutic potential 
into experimental medical and clinical practice is hampered by the poor plasma 
membrane permeability of these macromolecules. To overcome this major 
bottleneck, development of cellular delivery vectors has increasingly been in the 
focus of biomedical research.  
One class of very promising delivery tools is cell-penetrating peptides (CPPs), 
short amino acid sequences that are capable of efficient cellular transport of 
various bioactive macromolecules. The mechanisms and pathways of cellular 
entry of CPPs have been intensely studied in last two decades, and while it is 
widely acknowledged that these peptides internalize using different modes of 
endocytosis, the second internalization route – direct translocation through the 
plasma- or endosomal membrane, has remained elusive so far. Furthermore, 
despite the extensive research, the understanding of the exact role of specific 
cell surface molecules mediating the direct translocation of CPPs across mem-
branes is still controversial. 
The detailed identification of the molecular interactions with the plasma 
membrane constituents and more detailed knowledge about the exact inter-
nalization mechanism of CPPs would enable the design and efficient usage of 
these cellular delivery vehicles. Thus, the main purpose of this thesis was to 
pinpoint the specific binding partners of CPPs on the cell surface and the mem-
brane dynamics that enable direct translocation through the cellular membranes. 
The CPPs studied in this thesis are widely used representatives of the cationic, 
arginine-rich (nona-arginine and Tat peptide) and amphipathic (transportan, 
TP10, penetratin, MAP) peptide classes, which have proven to be efficient 
transporters for various macromolecular cargoes. 
The constant flow of cellular processes in living cells, including endocytosis, 
impedes assessment of direct translocation of CPPs across biomembranes. To 
overcome this obstacle, we, for the first time utilized in our studies simple and a 
highly relevant model membrane system – giant plasma membrane vesicles 
(GPMVs), that maintain the compositional complexity of biological membranes, 
but are devoid of endocytosis. By using GPMVs we demonstrate the role of 
several plasma membrane constitutes, as well as reveal the specific membrane 
composition, essential for the translocation. More precisely, we show that direct 
translocation of arginine-rich CPPs is mediated by protein component of the 
plasma membrane, and the internalization of these peptides can be increased via 
induction of ceramide in the membrane of GPMVs; while the membrane penet-
ration of amphipathic CPPs is strongly dependent on the lipid packing and takes 
place at more dynamic membrane regions. Finally, we show that glycosa-
minoglycans are crucial for the internalization of amphipathic peptides, while 
these cell surface polysaccharides have little influence on the direct crossing of 
arginine-rich CPPs through the membrane.  
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The current study provides an overview of the cell surface constituents that 
are required for the direct translocation of CPPs across membranes and analyses 
the lipid components of the membrane that facilitate or interfere with the 
cellular entry of CPPs.  
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1. LITERATURE OVERVIEW 
1.1 Cellular delivery systems 
A wide range of bioactive molecules, including potentially efficient drugs and 
gene therapeutics, are not applicable in clinical practice because of the poor 
translocation into cells through the protective lipid bilayer. Intracellular carrier 
systems have a vital role in overcoming this limiting step. The field of cellular 
delivery systems has therefore undergone an increasing and rapid progress over 
the past decades. A vast number of different chemical and physical methods and 
carriers for cellular transport have been developed for biomedical research, 
including electroporation, viral vectors, liposomes, microspheres, nanoparticles 
and polymers, microinjection, etc. However, the field still faces many challenges 
and the use of carrier systems is often hampered by their cellular toxicity, low 
efficacy and immunogenicity.  
In past three decades, peptide-based delivery vehicles have emerged as a 
powerful platform for the intracellular delivery. These amino acid sequences, 
capable of cellular transport, are called peptide transduction domains or simply 
cell-penetrating peptides (CPPs). CPPs are defined as “relatively short peptides, 
4–40 amino acids, with the ability to gain access to the cell interior by means of 
different mechanisms, mainly including endocytosis, and/or with the capacity to 
promote the intracellular effects by these peptides themselves, or by the delivered 
covalently or noncovalently conjugated bioactive cargoes.” (Langel 2015). 
Over the years, CPPs have been used to deliver numerous bioactive payloads 
that include peptides and proteins, oligonucleotides, plasmid DNA and silencing 
RNA, small-molecule drugs (reviewed in Meade and Dowdy 2007; Lehto et al. 
2012; Vasconcelos et al. 2013; Ramsey and Flynn 2015). By omitting funda-
mental shortcomings of many delivery systems, CPPs with a relatively low or 
no cytotoxicity (Saar et al. 2005; Tünnemann et al. 2008; Suhorutšenko et al. 
2011) and highly efficient delivery rates, were quickly recognized as powerful 
tools for the intracellular delivery of macromolecules that possess high bio-
medical and biotechnological potential. 
 
 
1.2 Cell-penetrating peptides 
First evidence that certain amino acid sequences are able to penetrate the plasma 
membrane emerged in 1988, when it was discovered that Tat protein from 
human immunodeficiency virus (HIV-1) is taken up by cells and can trans-
activate the viral promoter (Frankel and Pabo 1988; Green and Loewenstein 
1988). Few years later, another discovery confirmed the phenomenon of trans-
locating proteins when the group of A. Prochiantz showed that a homeodomain 
of the Antennapedia protein from Drosophila is able to penetrate the membrane 
of neurons (Joliot et al. 1991). The research field of CPPs was established in 
1994, when the same group discovered that the whole sequence of homeodo-
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main of Antennapedia is not necessary for the penetration and a 16 amino acid 
long peptide sequence is required for the translocation through the membrane 
(Derossi et al. 1994). Shortly after that, similar results were obtained with 
truncated versions of Tat protein (Vives et al. 1997; Schwarze et al. 1999). In 
1998, a chimeric peptide transportan was designed, which induced peptide nucleic 
acid transport into the cells (Pooga et al. 1998). Since these discoveries were 
made this field of research has expanded rapidly and new CPPs have been 
designed to use these peptides as transport vectors for the therapeutic and bio-
technologically important molecules. Large numbers of new CPPs have been 
found and to date, over 1850 peptides have cell-penetrating properties according 
to CPP database, gathered from research papers and published patents (Agrawal 
et al. 2016). CPPs can vary greatly in their length and amino acid sequence, 
causing major variations in their physicochemical properties. However, CPPs 
still hold some common features, such as relatively short length and most of 
them contain cationic amino acids; and are therefore positively charged at the 
physiological pH. Some CPPs are amphipathic, containing hydrophobic and 
hydrophilic amino acids (Zorko and Langel 2005; Ziegler 2008).  
In clinical setting it is critical that transport vectors that bind the cargo mole-
cules would transport the bioactive molecules into the cells with high efficiency 
and specificity without causing any side effects. CPPs have kept up with the fast 
pace of medical demands and the field of CPPs have been expanded tremen-
dously, as CPPs have been modified or new ones designed for improved cellular 
uptake (reviewed in Wang et al. 2014; Kurrikoff et al. 2016). Furthermore, 
CPPs have been incorporated into nanoparticles, liposomes and conjugated with 
other chemical moieties (Mäe et al. 2009; Biswas et al. 2013; Kurrikoff et al. 
2016) for the enhanced drug delivery and longer retention time. CPPs are also 
meeting the needs for the development of intelligent drug delivery systems that 
can be specifically targeted (Myrberg et al. 2008; Svensen et al. 2012; Teesalu 
et al. 2013). 
 
 
1.2.1 Classification of CPPs 
A high and still growing number of CPPs makes their classification a difficult 
task. However, two main approaches to classifying CPPs can be distinguished. 
The first and historical categorization is based on CPPs origin, dividing the 
peptides into three main classes: protein-derived (e.g Tat peptide), synthetic (e.g 
oligoarginine) and chimeric (e.g. transportan) peptides (Pooga and Langel 2015). 
The second and more common approach for grouping CPPs is based on the 
physicochemical properties of the peptides, which divides them into three major 
classes: cationic, amphipathic and hydrophobic (Milletti 2012). The first classi-
fication gives a good overview of the CPPs origin, but the second approach 
provides more information about the characteristics of the CPPs, and is therefore 
often preferred. CPPs used in this thesis, their origin and division into classes 
are presented in Table 1. 
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Table 1. Examples of cell-penetrating peptides 
Peptide Sequence Origin Ref. 
Cationic 
Oligo-
arginine  (R)n; n=6–12 
Synthetic 
Based on Tat peptide 
(Mitchell et al. 
2000) 
Tat peptide GRKKRRQRRRPPQ 
Protein-derived 
HIV-1 Tat Protein (48–60) 
(Vives et al. 
1997) 
Primary amphipathic 
Transportan GWTLNSAGYLLGKINLKALAALAKKIL 
Chimeric 
Galanin/Mastoparan 
(Pooga et al. 
1998) 
TP10 AGYLLGKINLKALAALAKKIL 
Chimeric 
Transportan analogue 
(Soomets et al. 
2000) 
Secondary amhipathic 
Penetratin RQIKIWFQNRRMKWKK 
Protein-derived 
Antennapedia homeodomain 
(43–58) 
(Derossi et al. 
1994) 
MAP KLALKLALKALKAALKLA 
Synthetic 
Model Amphipathic Peptide 
(Oehlke et al. 
1998) 
 
 
1.2.1.1 Cationic cell-penetrating peptides 
The majority of CPPs hold a net positive charge at physiological conditions 
(Milletti 2012), which stems from the abundance of cationic amino acids in the 
sequence of CPPs. Among positively charged amino acids like histidine, lysine, 
ornithine and arginine, the latter is by far the most common amino acid in the 
sequence of CPPs. For this reason, the class of cationic cell-penetrating peptides 
is sometimes also referred to as arginine-rich CPPs. In fact, arginine has shown 
to be the most efficient for inducing internalization among all the positively 
charged amino acids (Mitchell et al. 2000; Tünnemann et al. 2008; Åmand et 
al. 2008). Furthermore, peptides composed of only arginines have proven to be 
highly potent transporters, while poly-lysine, -ornithine and -histidine have poor 
cellular uptake (Mitchell et al. 2000; Tünnemann et al. 2008). The number of 
arginines is also an important parameter for efficient transduction. Polyarginines 
composed of less than 6 amino acids result in low internalization efficacies. 
Although longer sequences have better cellular uptake (less than 20 arginines), 
these have shown to be more cytotoxic (Mitchell et al. 2000; Futaki et al. 2001) 
and have elevated absorption to serum proteins (Kosuge et al. 2008), which in 
turn prevents the internalization. Therefore, the optimal number of arginine 
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residues has been considered to be between 8 and 12 (Futaki et al. 2001; 
Kosuge et al. 2008). Although cationic nature of arginine favours electrostatic 
interactions with negatively charged components of biological membranes, the 
positive charge is not the only parameter that can be attributed to the higher 
degree of internalization of arginine-containing CPPs, since the rest of the basic 
amino acids internalize in a much lower extent. Thus, the key property of 
arginine that determines the increased cellular uptake is its guanidinium group, 
which can form two hydrogen bonds with anionic compounds, like phosphates, 
sulfates and carboxylates, promoting the interactions with the membrane 
components; whereas lysine can only form one hydrogen bond (Mitchell et al. 
2000; Rothbard et al. 2004). It has been also proposed that lysine and arginine 
both induce negative curvature in membranes through electrostatic interactions, 
but the guanidinium group can also generate membrane positive curvature 
through multidentate bonds with lipid molecules. This results in the formation 
of saddle-splay curvature that was suggested to be the basis for the higher trans-
duction ability of arginine-containing peptides (Mishra et al. 2011).  
Other well-known and thoroughly studied arginine-rich CPPs are various 
amino acid sequences from the Tat protein (Vives et al. 1997). Tat is a trans-
cription factor that facilitates HIV-1 replication; and by testing many sequences 
from the range of amino acids, which are responsible for the translocation of the 
protein, it was found that out of the tested peptides, the amino acid sequence 48–
60 (GRKKRRQRRRPPQ) internalized most efficiently (Vives et al. 1997). 
Furthermore, this sequence also contains nuclear localization signal at the  
C-terminus (Ruben et al. 1989), which explains the high accumulation of the 
peptide into the nucleus (Vives et al. 1997). 
 
1.2.1.2 Amphipathic cell-penetrating peptides 
Some CPPs have distinguishable hydrophilic and hydrophobic regions and are 
therefore classified as amphipathic. This group can be further subcategorized as 
primary and secondary amphipathic CPPs (Ziegler 2008). Cationic and hydro-
phobic amino acids in primary amphipathic CPPs are ordered in a way that 
there is a clear separation between the respective hydrophilic and hydrophobic 
part in the structure of the peptide. The first region favours dissolution of the 
peptide in water and binding to the negatively charged groups in the membrane. 
The hydrophobic part facilitates interactions with the lipids (Deshayes et al. 
2004b; Fernandez-Carneado et al. 2004). One well-known primary amphipathic 
CPP is a chimeric peptide transportan (TP). TP is a 27 amino acid long peptide, 
containing 12 amino acids from the N-terminus of the neuropeptide galanin, 
which is conjugated through a lysine to 14 amino acids long wasp venom toxin 
peptide mastoparan (Pooga et al. 1998). Another well-known CPP belonging to 
this group is transportan analogue TP10, which has the same sequence as TP, 
but lacks 6 amino acids from the N-terminus (Soomets et al. 2000). By further 
modifying TP10, the next generation of efficient CPPs, PepFects and NickFects, 
have been created (Mäe et al. 2009; Oskolkov et al. 2011; Arukuusk et al. 
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2013a). Based on studies with artificial membranes, TP and TP10 both adopt an 
α-helical structure to a various degree (Soomets et al. 2000; Barany-Wallje et 
al. 2004). This amphipathic helix, as well as tyrosine moiety in the peptide 
sequence, was proposed to be necessary for the interactions and cellular uptake 
of TP and its analogues (Soomets et al. 2000). 
Secondary amphipathic peptides do not have distinctive hydrophilic and 
hydrophobic segments; however, these peptides acquire their amphipathic 
nature upon association with the membrane components, when the peptide 
adopts α-helical or β-strand secondary structure, where charged polar amino 
acids are located on one side and non-polar amino acids on another side 
(Fernandez-Carneado et al. 2004; Ziegler 2008). The most widely known and 
thoroughly studied secondary amphipathic CPP is a 16 amino acid long penet-
ratin; and as discussed above, it is derived from the third helix of Drosophila 
Antennapedia homeodomain of the homeoprotein (Derossi et al. 1994). 
Although penetratin is often classified as cationic, it acquires α-helical structure 
in the presence of negatively charged lipids (Alves et al. 2008; Maniti et al. 
2010), a common characteristic of secondary amphipathic peptides; whereas in 
the presence of neutral lipids, no defined secondary structure could be observed 
(Maniti et al. 2010). The prototypic representative of secondary amphipathic 
peptides is an 18 amino acid long MAP (model amphipathic peptide) (Oehlke et 
al. 1998). Upon interacting with the membrane, MAP forms a perfect α-helical 
structure, resulting from the specific order of positively charged amino acid 
lysine and hydrophobic amino acids leucine and alanine. Due to these amino 
acids, this peptide is also often called KLAK. 
 
1.2.1.3 Hydrophobic cell-penetrating peptides 
Only a few members of CPPs fall into this category. The representatives of this 
CPP class consist mostly of hydrophobic amino acids and contain only a low 
number of cationic or even anionic amino acids. For example, Pep-7 is mostly 
hydrophobic, but also contains few anionic amino acids in its sequence, yielding 
the net negative charge –2 (Gao et al. 2002).  
 
 
1.3 Mechanisms of CPP internalization 
Endocytosis is the primary cellular internalization pathway for the majority of 
macromolecules. Therefore, the early understanding that CPPs avoid endocytosis 
and can directly penetrate through the membrane was rather unconventional. 
However, not long after their discovery, it was demonstrated that CPPs 
internalize also via different types of endocytic routes; and by now it is well 
established that the cellular uptake of CPPs involves both pathways, endocytosis 
and direct translocation. The cellular internalization route depends strongly on 
the peptide sequence, its physicochemical properties (Tünnemann et al. 2006; 
Jiao et al. 2009), target cell or tissue type (Tünnemann et al. 2006; Duchardt et 
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al. 2007; Jiao et al. 2009), peptide concentration (Duchardt et al. 2007; Kosuge et 
al. 2008; Jiao et al. 2009; Melikov et al. 2015), size and physicochemical nature 
of the cargo, attached to the peptide (Erazo-Oliveras et al. 2012). 
 
 
1.3.1 Direct translocation 
Early research in the field of CPPs revealed that these peptides can directly 
penetrate the cellular membrane and the internalization does not require cellular 
energy, and therefore it is independent of endocytosis. Although, since then, a 
great number of studies have demonstrated that the cellular uptake of CPPs 
proceeds mostly via different endocytosis pathways, it is also well established 
by now that the unique internalization pathway of CPPs – direct translocation 
through the membrane is frequently utilized. This unconventional internalization 
of CPPs via direct penetration raises the question, how CPPs can directly 
surpass the protective lipid bilayer, while other macromolecules gain access to 
cells via endocytosis. There is a great volume of studies describing the penetration 
mechanism, but several controversies still exist. An overview of some of the 
most well-appreciated mechanisms and models of direct translocation will be 
presented below. 
 
Inverted micelle model 
The first model proposed to explain the mechanism of CPP translocation was 
the inverted micelle model suggested for the internalization of penetratin to 
cells (Derossi et al. 1996). According to this model, the electrostatic interactions 
between the CPP and negatively charged membrane components facilitate the 
accumulation of the peptide to the plasma membrane. This leads to inva-
ginations, which in turn will be covered with lipids, resulting in the formation of 
a micelle, where the peptide localizes inside the hydrophilic cavity. The peptide 
trapped in the micelle destabilises the membrane and is subsequently released 
into the cytoplasm (Figure 1A) (Derossi et al. 1996). Later, it was shown that 
penetratin can induce non-lamellar lipid structures in model membranes and as 
in the study discussed above, the formation of inverted-micelle like structures 
was reasoned to be the method for direct translocation through the lipid bilayer 
(Alves et al. 2008). Other arginine-rich CPPs, such as pTat and Arg9, but also 
hydrophobic amino acid-containing R6/W3, have been demonstrated to operate 
through the same mechanism, supporting the concept that direct penetration can 
include the formation of inverted micelle-like structures (Afonin et al. 2006; 
Swiecicki et al. 2014). 
 
Pore formation 
Many CPPs share some common features with antimicrobial peptides, such as 
positive charge, amphipathicity and relatively short sequence (Melo et al. 2009). 
Therefore, several internalization mechanisms, such as pore formation that are 
attributed to antimicrobial peptides, have been also proposed as the direct trans-
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location modes of CPPs. According to a barrel-stave pore, the peptide inserts 
into the membrane perpendicularly and forms a helix, with the hydrophobic 
amino acids facing the membrane. Hydrophilic amino acid residues form the 
internal part of the pore, giving rise to a structure that resembles a barrel (Figure 
1B) (Lundberg and Langel 2003).  
The second proposed model is a toroidal pore, where similarly to barrel-
stave, the peptide inserts into the membrane in a perpendicular orientation. Inter-
actions between the peptide and phospholipid head groups result in the 
induction of the membrane curvature and the formation of a pore, where lipid 
head groups partially line the lumen of the pore (Figure 1C). A modification of 
this model is a disordered toroidal pore, where similar structures form, but the 
insertion of the peptide into the membrane is more stochastic (Melo et al. 2009).  
According to the carpet model, cationic CPPs interact with negatively 
charged phospholipids and CPPs cover the membrane by orienting themselves 
in parallel to the bilayer, similarly to a carpet. At higher peptide concentrations, 
although no permanent pore is formed, the plasma membrane is disrupted, 
which results in the displacement of the phospholipids and leads to the inter-
nalization of peptides (Figure 1D) (Lundberg and Langel 2003). 
 
 
Figure 1. Translocation models of CPPs. A. Inverted micelle model. The peptide 
accumulates to the plasma membrane leading to invaginations, which will be covered 
with lipids. This results in the formation of a micelle, where the peptide localizes inside 
the hydrophilic cavity. The peptide trapped in the micelle destabilises the membrane 
and is subsequently released into the cytoplasm B. Barrel-stave pore. The peptide 
inserts into the membrane perpendicularly and forms a barrel-like structure C. Toroidal 
pore. The peptide inserts into the membrane in a perpendicular orientation. Peptide 
induces membrane curvature and the formation of a pore, where lipid head groups 
partially line the lumen of the pore D. Carpet model. Peptides cover the membrane by 
orienting themselves in parallel to the bilayer, similarly to a carpet. At higher peptide 
concentrations, the membrane is disrupted, which results in the displacement of the 
phospholipids and internalization of the peptides. 
18 
Although none of the above-mentioned models has a real factual proof as mem-
brane permeabilization mechanisms for CPPs, numerous studies, predominantly 
with model lipid bilayers, suggest that pore formation is indeed one of the 
penetration mechanisms. Formation of a pore is usually anticipated when the 
internalization of the peptide into liposomes is accompanied by an influx or 
efflux of dye or dextran molecules of various sizes. By using these tracer mole-
cules, it was demonstrated that Tat peptide can form pores of nanometer-size 
(Ciobanasu et al. 2010). However, a relatively high concentration of anionic or 
negative curvature-inducing lipids was required for induction of pores and 
vesicle disruption. A few other studies have proposed that the induction of 
membrane curvature precedes pore formation by Tat peptide (Mishra et al. 
2008; Mishra et al. 2011). The formation of pore-like structure has been also 
suggested as the internalization mechanism for Pep-1 and MPG peptide 
(Deshayes et al. 2004a; Deshayes et al. 2006). Both peptides adopt α-helical 
and β-sheet secondary structures in the presence of lipids, respectively. These 
secondary structures are commonly found in the polypeptide chains in trans-
membrane proteins, which traverse the lipid bilayer as a single or multiple  
α-helix/helices or as a β-sheet that form barrel-like structures (Alberts et al. 
2013); and similarly could favour the interactions of CPPs with the membrane. 
Furthermore, the majority of these polypeptides in transmembrane proteins 
form an α-helix, where approximately 20 amino acids are required to cross the 
cell membrane (Alberts et al. 2013). If to draw parallels, only some CPPs, such 
as transportan and TP10, could theoretically span through the membrane in a 
similar fashion. Furthermore, both transportans are amphipathic and adopt the 
respective secondary structure similarly to some antimicrobial peptides that are 
prone to form pores in the membrane (Melo et al. 2009). This concept is sup-
ported by several studies, which proposed that the internalization of TP10 was 
accompanied by the formation of pores (Anko et al. 2012; Islam et al. 2014). 
Carpet-like membrane destabilization upon penetration of TP10 into cells has 
been also observed (Yandek et al. 2007). However, in general, carpet-like 
internalization would require high local concentration of the peptide (Shai and 
Oren 2001), which might not reflect the real situation in vivo. Similarly, the 
probability of the formation of the permanent barrel-stove pore has been 
proposed to be rather low, as for macromolecule passage, at least 20 peptides 
are needed for the formation of the “ring” that would have to be stable (Wimley 
2015). In light of this view, if one of the aforementioned models would apply, 
the most probable scenario would include the formation of the (disordered) 
toroidal pore-like temporal membrane destabilization, as recently suggested by 
Wimley (Wimley 2015). 
 
Destabilization and reorganization of lipid bilayers 
Besides the aforementioned models, many other mechanisms have been pro-
posed for CPP penetration that include destabilization and reorganization of 
membranes. For example, dodeca-arginine was demonstrated to internalize via 
induction of particle-like multilamellar structures (Hirose et al. 2012). Similarly, 
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nona-arginine and amphipathic peptide RW9 were shown to provoke the 
formation of multilamellar membrane particles on the surface of the plasma 
membrane spheres (Maniti et al. 2014). Furthermore, according to the same 
study, the membrane permeabilization of two amphipathic CPPs, RW9 and 
RW16, included segregation of membrane`s lipid phases; a similar penetration 
mechanism was observed earlier in the case of penetratin (Lamaziere et al. 
2010). 
 
Internalization from boundary regions between lipid phases  
Research into the membrane composition-dependent translocation suggests that 
CPPs might internalize via the boundary regions of either peptide-induced or 
innate lipid phases of membranes. In the case of the first mode, the internalization 
of a nona-arginine peptide was shown to induce the formation of ceramide-
enriched regions in the plasma membrane. The penetration of nona-arginine into 
cells was proposed to take place at the boundary regions of those “rafts” and the 
rest of the membrane, at so-called nucleation zones (Verdurmen et al. 2010). 
Similarly, nucleation zones have been previously described as translocation 
sites into cells also for nona-arginine and Tat peptide at higher concentrations 
(Duchardt et al. 2007). Peptide-induced lateral lipid phase separation and 
resulting defect lines in the interface region between different domains were 
suggested to be also favourable sites for translocation of S4(13)-PV peptide 
(Cardoso et al. 2012). Furthermore, CPP-induced lipid segregation and intern-
alization from the membrane “defect” regions with higher fluidity has been 
suggested for several other peptides as well (Joanne et al. 2009). The lipid “fault 
lines” could indeed present favourable sites for the reorganization of lipids and 
subsequent penetration, as lipid phase boundary regions could lower the energy 
that is needed for the charged peptides to cross the membrane. 
 
Membrane tubulation and physical endocytosis 
Studies with model membrane systems demonstrate that some CPPs can also 
induce membrane tubulation and invagination termed as “physical endocytosis” 
(Lamaziere et al. 2007; Lamaziere et al. 2008; Maniti et al. 2012). For example, 
penetratin can induce negative curvature in model membranes (Lamaziere et al. 
2008). However, by using vesicles with different lipid composition, which mimic 
membranes with a varying degree of lipid-packing density, penetratin was able 
to induce membrane curvature and tubulation only in vesicles that had higher 
membrane fluidity. Analogous results were also obtained with plasma membrane 
spheres, which by their constitution resemble plasma membrane very closely 
(Maniti et al. 2012). Furthermore, several other studies have demonstrated the 
formation of CPP-induced tubular structures (Lamaziere et al. 2007; Lamaziere et 
al. 2010; Anko et al. 2012) and consecutive tubule rolling (Maniti et al. 2014). 
Lamaziere et al. systematically analysed the membrane activity of several 
basic and amphipathic CPPs in relation to their length, amphipathicity and total 
charge. Their study reveals that cationic non-amphipathic CPPs induce membrane 
aggregation, tubulation and negative curvature in the membrane, while am-
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phipathic CPPs induce membrane deformations (pores), the formation of 
tubular structures, and generation of small vesicles (physical endocytosis). 
Cationic CPPs and shorter amphipathic peptides, in contrary, could not induce 
pores (Lamaziere et al. 2007). 
 
 
1.3.2 Endocytosis 
Endocytosis is the “digestive” system of the cell that involves two types of basic 
uptake modes: phagocytosis and pinocytosis. The former is responsible for taking 
up large particles into cells and the latter facilitates the ingestion of smaller 
molecules and fluid. Phagocytosis occurs only in specific cells like macro-
phages, while pinocytosis is common for all eukaryotic cells (Alberts et al. 2013). 
Extracellular fluid and macromolecules, including CPPs, are transported into 
cells via different routes of pinocytosis, which are classified as macropinocytosis, 
clathrin-mediated endocytosis (CME), caveolae-mediated endocytosis, and 
caveolae- and clathrin-independent endocytosis (Kumari et al. 2010).  
Macropinocytosis is considered to be largely a non-selective endocytic route, 
through which bigger particles that are attached to the plasma membrane, as 
well as membrane and fluid with solutes are ingested (Swanson 2008). The 
induction of macropinocytosis is regulated through signalling and is induced 
upon stimuli. The exact regulation, however, has remained elusive so far, but has 
been shown to be dependent on actin and cholesterol (Doherty and McMahon 
2009). This pathway usually entails membrane protrusions and ruffling, resulting 
in the formation of vesicles that can be up to a few µm-s in size (Swanson 
2008). A large and growing body of literature, describing CPP endocytic entry, 
has considered macropinocytosis as one of the prime pathways for CPP-cargo 
uptake (Nakase et al. 2004; Wadia et al. 2004; Kaplan et al. 2005; Duchardt et 
al. 2007; Nakase et al. 2007). Furthermore, there is very little evidence that 
CPP-cargo complex would interact with plasma membrane receptors, which 
would often induce an internalization pathway of higher specificity.  
CME is typically triggered by the binding of a ligand molecule to its receptor 
and a wide variety of different cargo molecules utilize this pathway (Doherty 
and McMahon 2009). After the initiation of CME, the uptake of material and 
the vesicle formation is mediated by the clathrin coat. The size of formed vesi-
cles depends on the properties of the cargo and they are markedly smaller than 
macropinosomes, usually not exceeding 200 nm in diameter (McMahon and 
Boucrot 2011). In parallel with macropinocytosis, CME has been often shown 
to mediate the cellular uptake of CPP-cargo constructs (Richard et al. 2005; 
Hassane et al. 2011). Moreover, CME often serves as a complementary pathway 
to macropinocytosis (Petrescu et al. 2009), which supports the notion that the 
internalization of CPPs is not restricted to one endocytic pathway, but rather 
involves several mechanisms, which might function in parallel. 
Caveolin/caveolae-mediated endocytosis appears to be a rather infrequent 
pathway of cellular uptake harnessed by CPPs. The reason might lie in the fact 
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that this endocytic route regulates many specific cell-signalling cascades, which 
are typically activated by a ligand binding to its receptor. The formed vesicles 
are relatively small, approximately 120 nm of diameter (Kumari et al. 2010), 
and thus, could limit the uptake of bigger CPP-cargo complexes. Nevertheless, 
caveolin-mediated endocytosis has been shown to mediate the cellular uptake of 
full-length Tat protein and Tat peptide conjugated to a protein cargo (Ferrari et 
al. 2003; Fittipaldi et al. 2003; Säälik et al. 2009), as well as transportan and 
TP10 (Säälik et al. 2009). However, the contribution of this particular pathway 
to the uptake of CPP-cargo was shown to be moderate; and as stated before, 
alternative routes are probably exploited in parallel (Säälik et al. 2009). 
Several other endocytosis pathways have been discovered recently, which are 
grouped as clathrin- and caveolin-independent endocytosis, including CLIC/ 
GEEC-type endocytosis, Arf6 dependent and flotillin-dependent endocytosis 
(Doherty and McMahon 2009; McMahon and Boucrot 2011). However, these 
have not shown to contribute to the internalization of CPPs, perhaps because of 
the insufficient understanding of these cellular transport routes compared to 
what is known about the aforementioned endocytic pathways. 
In general, one common endocytic route cannot be attributed to all CPPs, 
since the utilized pathway depends on several factors. Furthermore, the inter-
nalization can involve many concurrently acting pathways, and if one is down-
regulated, CPPs can swiftly switch to another internalization mode (Duchardt et 
al. 2007).  
 
 
1.3.2.1 Endosomal escape 
Ingested material, including CPPs, end up in early endosomes, where it is further 
directed to either recycling route for externalization or to degradation pathway. 
In order to exert its biological effect, CPP-cargo construct has to escape from 
the endosomes to avoid these pathways. In principle, two possible scenarios 
exist to achieve that: CPPs have to either translocate through the endosomal 
membrane or rupture it. Translocation seems a more plausible explanation, as 
membrane rupture would cause cytotoxic effects, which are usually not observed. 
Regardless of the endosomal escape mechanism, one of the key questions is 
why the escape from endosomes occurs, while the plasma membrane remains 
impenetrable. One explanation for this divergence stems in the different 
composition of the endosomal and plasma membrane. In line with this, higher 
content of anionic lipids has been shown to promote the interactions with the 
membrane and subsequent translocation of CPPs (Ciobanasu et al. 2010). Since 
the membrane of endosomes contains more anionic lipids, this could result in 
the increased endosomal escape (van Meer et al. 2008; Erazo-Oliveras et al. 
2012). Moreover, some CPPs are known to change conformation in the presence 
of anionic lipids (Alves et al. 2008). A change in the conformation that is 
induced upon interaction with anionic lipids in the membrane of endosomes 
could facilitate the subsequent escape. Another explanation proposed for the 
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preferred penetration through the endosomal membrane as opposed to the 
plasma membrane, is that the electrostatic interactions between the cell surface 
proteoglycans and CPPs interfere with the association of the peptide with lipids. 
However, in endosomes, proteoglycans are gradually hydrolysed, as endosomes 
mature, and CPPs can interact with lipids, leading to their penetration through 
the endosomal membrane (Fuchs and Raines 2004). A higher peptide to lipid 
ratio could be the major determinant for the escape of CPPs from the 
endosomes, since the local peptide concentration is much higher in endosomal 
vesicles compared with the plasma membrane, and this might trigger liberation 
of CPPs from endosomes. This view is supported by a recent study where 
endosomal membrane-mimicking vesicles were used to study the endosomal 
escape of various arginine-rich cyclic peptides. Remarkably, the translocation 
efficacy of CPPs was dependent on the endosomal membrane-binding affinity 
(Qian et al. 2016). Furthermore, the cyclic peptide was shown to penetrate 
through the membrane without causing a remarkable efflux of the reporter dye 
trapped in “endosomes”, indicating that the escape of CPPs from these vesicles 
did not induce membrane rupture or formation of permanent pores. 
Several different strategies have been implemented to enhance the efficiency 
of cargo delivery by CPPs by increasing the endosomal escape while avoiding 
the damage to the plasma membrane. One approach is to harness the anti-
microbial peptides that destabilize the membrane of endosomes, which was 
recently used to increase the efficacy of Tat-mediated plasmid DNA transport 
into cells (Salomone et al. 2013). The authors suggested that during the endo-
somal trafficking, the complex of plasmid DNA with CPP is partially dis-
sociated, which results in the release of the antimicrobial peptide that might 
destabilize the endosomal membrane. Another common strategy exploits fusion 
peptides from influenza virus hemagglutinin. Upon acidification of endosomes, 
the pH sensitive fusion peptide destabilizes the limiting membrane and facili-
tates the escape of cargo molecules into the cytosol. Thus, the exploitation of 
the pH differences between the endosome lumen and the plasma membrane 
avoids the damage to the latter. This method was efficiently utilized for co-
incubation of protein cargo with the Tat-fusion peptide conjugate, which 
markedly increased the endosomal release (Wadia et al. 2004). In the same 
study, a lysosomotropic agent chloroquine was used to increase the endosomal 
release; however, it led to a very high cytotoxicity. Chloroquine inhibits acidi-
fication of endosomes and induces swelling and subsequent rupture of endo-
somal vesicles. This property of chloroquine was utilized in the design of some 
of the PepFect family peptides, introducing a modification with its analogue – 
trifluoromethylquinoline. This moiety has been very potent in facilitating the 
cargo escape from the endosomes and thereby augmenting its biological effect 
(Andaloussi et al. 2011; Lindberg et al. 2013). Furthermore, all the CPPs in the 
PepFect and NickFect family are chemically modified with a stearyl group, 
which increases the lipophilicity of the peptides and membrane-destabilizing 
properties (Mäe et al. 2009; Oskolkov et al. 2011). 
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1.4 Plasma membrane and its constituents 
1.4.1 Glycocalyx 
Cell surface is covered with carbohydrates that form a network called glyco-
calyx, and this “cell coat” mainly consists of glycans. Glycans are carbohydrates 
that can be assembled from different combinations of monosaccharides fucose, 
galactose, glucose, N-acetylgalactosamine, N-acetylglucosamine, glucuronic 
acid, iduronic acid, mannose, sialic acid and xylose (reviewed in Moremen et 
al. 2012). These structural variations give rise to a vast collection of glycans that 
can be further modified with the phosphate, sulfate, or acetyl esters (Bertozzi 
and Rabuka 2009), which broadens their diversity even more. Glycans are 
found in the composition of glycolipids, glycoproteins, and proteoglycans. 
Glycolipids are lipids that contain one or more monosaccharide(s) in their 
head group. The most abundant glycolipids in the eukaryotic cell membrane are 
glycosphingolipids, where glycan group is attached via glucose or galactose to 
the terminal primary hydroxyl group of the lipid moiety ceramide (Varki and 
Sharon 2009). Glycosylphosphatidylinositol (GPI) is a distinct type of glyco-
lipid, which is added to some proteins to anchor these to the plasma membrane. 
Gangliosides form another family of glycolipids that contain one or more sialic 
acid residues, which gives the lipid a negative charge. Glycolipids localize 
exclusively on the outer layer of the plasma membrane, glycan part facing the 
cell exterior (Alberts et al. 2013). The carbohydrate content in glycolipids is 
relatively modest, usually less than 15 sugar units (Alberts et al. 2013). Moderate 
carbohydrate content applies also to glycoproteins, which mainly consist of a 
protein core and bear a low number of glycans. The carbohydrate content is 
highest in proteoglycans (PG) that are composed of long linear branches of 
glycosaminoglycans (GAGs) attached to a core protein. PGs can be secreted 
into the extracellular matrix (e.g. aggrecan family), stored in secretory granules 
(e.g. serglycin) or attached to the plasma membrane. Membrane-bound PGs can 
be linked to the lipid bilayer via GPI anchor (glypican family) or by its 
hydrophobic transmembrane domain (e.g. syndecan family) (Esko et al. 2009). 
Although PGs can also contain O- and N-glycans that are typically attached to 
glycoproteins, the vast majority of carbohydrates on PGs are bulky GAG chains 
(Esko et al. 2009). There is a huge heterogeneity within proteoglycans, resulting 
from various types of core proteins, but also from the diverse number, length, 
and sulfation levels of GAGs attached to PGs (Esko et al. 2009). 
 
1.4.1.1 Glycosaminoglycans 
Glycosaminoglycans (GAGs) are negatively charged linear polysaccharides that 
consist of disaccharide repeating units. These units are composed of uronic acid 
(glucuronic acid or iduronic acid) or galactose and an amino sugar (either  
N-acetylglucosamine or N-acetylgalactosamine). This structural variety is the 
basis for the different types of GAGs that include hyaluronic acid, heparin and 
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heparan sulfate, chondroitin sulfate, dermatan sulfate and keratan sulfate. GAGs 
can be found as a free complex or covalently attached to a protein, forming PGs 
(Esko et al. 2009). Glycosaminoglycans form large structures, the molecular 
weight ranging usually between 1–2,000 kDa (Coccheri and Mannello 2014); 
and are highly negatively charged due to the uronic acids in their backbone and 
extensive sulfation (Ernst et al. 1995). The repeating structural units of different 
classes of glycosaminoglycans and the average number of disaccharides in one 
chain is presented in Table 2. 
Heparan sulfate (HS) is widely found all over the body and it is produced by 
virtually all cell types (Esko et al. 2009). Heparin (HP) is structurally analogous 
to HS, although HP is synthesized only in specific cells (mostly primary mast 
cells). Both, HS and HP, consist of repeating units of glucuronic acid and  
N-acetylglucosamine (Esko et al. 2009). HS and HP chains can be long, the 
molecular weight ranging from 10–70 kDa and 7–20 kDa, respectively; and are 
usually heavily modified with 0- and N-sulfation. However, heparin has even 
higher degree of sulfation compared with heparan sulfate (Esko et al. 2009). HS 
is abundantly found in the composition of various PGs, namely heparan sulfate 
proteoglycans (HSPGs). HSPGs act as (co)receptors and mediate various vital 
cellular processes, such as signalling and transport, to name a few (Sarrazin et 
al. 2011). One of the examples of HSPGs is the syndecan family. The members 
of this HSPGs family carry only HS chains (syndecan-2 and syndecan-4), or 
also chondroitin sulfates (syndecan-1 and syndecan-3) (Esko et al. 2009).  
Chondroitin sulfate (CS) is the most abundant GAG in the body, found in 
cartilage, bones, cornea, etc. The members of this class of polysaccharides are 
involved in various physiological functions, such as wound healing, infections, 
cell division; and also participate in different signalling pathways (Coccheri and 
Mannello 2014). CS form long and heavy chains (15 to 70 kDa) consisting of 
repeating disaccharide units of N-acetylgalactosamine and glucuronic acid 
(Ernst et al. 1995). The degree of sulfation can vary greatly, as well as the posi-
tion of the sulfate group; the latter giving rise to CS subclasses: chondroitin 
sulfate A, C, D and E (Coccheri and Mannello 2014).  
Dermatan sulfate (DS), also known as chondroitin sulfate B, is structurally 
similar to CS, containing N-acetylgalactosamine. However, instead of glucuronic 
acid, DS consist of a varying degree of iduronic acid. Similarly to the other 
GAGs, the position of the sulfate group can vary. DS chains are usually shorter 
(15 to 55 kDa), forming smaller PGs that are widely spread in skin (Ernst et al. 
1995; Coccheri and Mannello 2014). 
Keratan sulfate (KS) is composed of N-acetylglucosamine, and unlike other 
GAGs, KS contains galactose instead of uronic acid. The molecular weight of 
the KS chains usually varies between 2–20 kDa; and almost all glucosamine and 
some galactose units contain sulfate groups (Ernst et al. 1995). KS is widely 
found in bones, cartilage and nerve tissue (Coccheri and Mannello 2014).  
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Table 2. The structural units of glycosaminoglycans (adapted from Lodish et al. 2000) 
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Hyaluronic acid (HA), also called hyaluronan, consists of N-acetylglucosamine 
and glucuronic acid. Unlike other GAGs, which are synthesised in the Golgi 
complex, HA is formed by integral membrane proteins at the plasma membrane. 
Another property that differentiates HA from the aforementioned GAGs is the 
lack of sulfate groups. However, HA is still negatively charged due to the 
presence of glucuronic acid (Hascall and Esko 2009). Furthermore, HA is not 
covalently linked to PGs, but instead forms massive polysaccharide complex, in 
which a single chain can consist of 25 000 repeating disaccharide units (Alberts 
et al. 2013). Long HA chains are binding sites for proteoglycans, which in turn 
are linked with other GAGs. Hyaluronan can be found in various concentrations 
in extracellular matrix everywhere in the body (Hascall and Esko 2009). 
 
 
1.4.1.2 Glycans and CPPs 
Cell surface is heavily decorated with glycans, which perform various physio-
logical functions (Varki and Lowe 2009). Given their abundance, the inter-
nalization of CPPs is likely to involve interactions with glycans as a first step. A 
considerable amount of literature has been published on the role of glycans in 
CPP transduction, where the involvement of GAGs in the internalization of 
CPPs has been studied the most intensively. GAGs form huge complex struc-
tures and are highly negatively charged. Since the majority of CPPs are 
cationic, strong electrostatic interactions between them are highly probable. 
Indeed, high affinity of CPPs towards GAGs has been demonstrated in many 
reports (Fuchs and Raines 2004; Ziegler and Seelig 2004; Goncalves et al. 
2005). Furthermore, the higher degree of GAG sulfation, and thus higher nega-
tive charge, was shown to correlate with the binding efficacy of the Tat peptide 
to GAGs (Ziegler and Seelig 2004). In addition, treating cells with agents that 
block GAG sulfation resulted in the decreased cellular uptake of Tat peptide 
(Sandgren et al. 2002; Letoha et al. 2010), octa-arginine and penetratin (Letoha 
et al. 2010). Moreover, numerous studies conducted with the cell lines that lack 
GAGs or only HS have demonstrated that internalization efficacy of arginine-
rich CPPs, such as Tat peptide, oligoarginines and penetratin, is markedly lower 
into HS-deficient cells; and even more so in the case of cells that lack all GAGs 
(Console et al. 2003; Fuchs and Raines 2004; Richard et al. 2005; Nakase et al. 
2007). According to one study, the uptake of octa-arginine was less dependent 
on HSPGs compared with the Tat peptide (Nakase et al. 2007). It was proposed 
that this resulted from the higher charge density of octa-arginine, which enabled 
interactions with other GAGs when HSPGs were lacking; as opposed to Tat 
peptide that could only interact with HSPGs, which had higher sulphuric acid 
content, compared with the rest of the GAGs (Nakase et al. 2007). It has been 
also pointed out that CPP concentration influences peptide-GAG interactions. 
At lower concentrations, the internalization efficacy into GAG-deficient cells 
was similar to that of wild-type cells, while at higher concentrations, the accu-
mulation into a HS-deficient cell line was considerably lower (Kosuge et al. 
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2008). Furthermore, the presence or lack of GAGs influenced also the con-
centration at which the peptide “switches” from endocytosis to translocation. It 
was shown that the absence of GAGs increased the concentration that was 
needed for inducing translocation, that otherwise replaced endocytosis already 
at lower concentrations (Kosuge et al. 2008).  
Syndecans, a family of HSPGs, has been reported to mediate the cellular 
uptake of arginine-rich CPPs. Syndecans are transmembrane PGs that carry 
either HS or HS/CS chains. A significant increase in the uptake of octa-arginine 
and Tat-peptide was detected into cells that overexpressed syndecan-2 (Nakase 
et al. 2007). Similar results were obtained in another study where cells 
expressing specific syndecan variants were utilized to demonstrate that all 
syndecans, but particularly syndecan-4, mediate the entry of octa-arginine, Tat 
peptide and penetratin into cells (Letoha et al. 2010). Furthermore, it was 
emphasized that HS chains have a crucial role in binding to syndecans, and 
cytosolic co-localization of these with the peptides was detected. These results 
were corroborated by a recent study demonstrating that the internalization of 
octa-arginine via clathrin-mediated endocytosis was induced by syndecan-4 
(Kawaguchi et al. 2016). 
Several recent studies investigating the GAG-dependent uptake of CPPs 
have uncovered the CPPs ability to cluster these molecules. HSPG clustering by 
pTat was observed when multiple pTat molecules were conjugated to quantum 
dots. Cross-linking of these PGs resulted in the initiation of a signalling cascade 
that induced the uptake of CPPs via macropinocytosis. These effects were not 
detected when a quantum dot was linked to only two pTat molecules (Imamura 
et al. 2011). It was further demonstrated that eight pTat molecules were neces-
sary so that each individual nanoparticle would induce the uptake by cross-
linking HSPGs (Suzuki et al. 2013). These results indicate that a certain number 
of peptide molecules is needed for GAG-clustering and the induction of endo-
cytosis. GAG-clustering ability has been also demonstrated for amphipathic 
peptides, TP10 analogues (Verdurmen et al. 2013). However, it did not result in 
enhanced uptake, although enzymatic removal of HS or competitive binding 
resulted in reduced cellular uptake. It was further demonstrated that arginine 
residues and peptide cyclization are beneficial for cross-linking HS, which 
results in the increased uptake efficacy (Wallbrecher et al. 2014). It was also 
proposed that peptides with the lower binding stoichiometry can cross-link HS 
more efficiently, which in turn leads to the clustering of PGs at the cell mem-
brane and higher cellular uptake, while strong binding reduces the capacity to 
cross-link HS in such a manner that would lead to peptide internalization. 
Similarly, the transduction of WR9 peptide has been previously demonstrated to 
depend on the ability of the peptide to cluster GAGs (Ziegler and Seelig 2011). 
According to the another study, tryptophan-rich CPP was shown to adopt  
β-strand secondary structure upon interacting with GAGs, which led to the for-
mation of more stable GAG aggregates and increased internalization efficacy 
(Bechara et al. 2013). It was further demonstrated that the internalization of 
tryptophan-containing peptides, penetratin and R6W3, was even more enhanced 
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when the formation of ceramide in the plasma membrane was induced. The 
formation of ceramide was proposed to mediate GAG clustering, which in turn 
benefits for the cellular entry of these peptides; confirming the importance of 
GAG cross-linking in the internalization of CPPs (Bechara et al. 2015). Further-
more, it has been also proposed that the stability of the CPP-induced clusters 
determines the subsequent internalization pathway, as it was demonstrated that 
penetratin forms more stable clusters than Tat peptide and induces endocytosis, 
while Tat peptide may dissociate from GAGs and eventually translocate (Rullo 
et al. 2011). 
Despite a large number of studies demonstrating the prime role of GAGs in 
CPP internalization, contradictory results have been obtained several times. For 
instance, Tat peptide was shown to internalize independently of HSPGs (Silhol 
et al. 2002). Similarly, internalization efficacy of Tat peptide was not impaired 
neither by enzymatic removal of HS or sialic acids, nor was the uptake effi-
ciency reduced into cells deficient in those glycans (Gump et al. 2010). These 
results were corroborated by another study demonstrating that the cellular 
uptake of penetratin was equally efficient into wild-type, GAG- and sialic acid-
deficient cell lines (Alves et al. 2011). However, these results were obtained only 
at low peptide concentrations, while higher concentrations resulted in reduced 
uptake into GAG-deficient cells and interestingly, increased internalization 
efficacy into sialic acid-deficient cells. Also, it has been suggested that GAGs 
can facilitate the cellular uptake of CPPs to some extent, but these poly-
saccharides are not the main binding partners, as studies with GAG-deficient cell 
lines or degradation of these carbohydrates by enzymes never abolished the 
uptake completely (Brock 2014). Nevertheless, based on numerous studies, the 
indispensable role of GAGs as mediators of cellular uptake of CPPs cannot be 
refuted. 
 
 
1.4.2 Plasma membrane proteins as receptors for CPPs 
Plasma membrane is heavily loaded with proteins, which count for about 50% 
of the membrane mass. Proteins carry numerous vital functions such as cell 
communication, adhesion and trans-membrane transport, including the uptake 
of the majority of macromolecules (Alberts et al. 2013). The involvement of 
proteins in the internalization of CPPs has been seldom demonstrated. Indi-
cations of protein-facilitated CPP uptake started to emerge when it was demon-
strated that degradation of proteins from the cell surface blocked the macro-
pinocytotic internalization of pTat and cargo protein (Gump et al. 2010). After 
that, only a few recent studies have revealed the role of membrane receptors in 
the transduction of some CPPs. For instance, the internalization of a peptide 
composed of 12 arginines was shown to be mediated by a chemokine receptor 
CXCR4 (Tanaka et al. 2012). Interestingly, the receptor did not participate in 
the internalization of the shorter oligoarginine (R8) or Tat peptide. According to 
another recent study, the cellular entry of nanoparticles coated with Tat peptide 
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required a transmembrane receptor neuropilin-1 and heparan sulfates (Pang et 
al. 2015). Similarly, neuropilin-1 has been previously reported to regulate the 
cellular uptake of tumor-penetrating peptides (Teesalu et al. 2009; Sugahara et al. 
2015). Recently, scavenger receptors were found to mediate the uptake of the 
second-generation CPPs, PepFects and NickFects. However, the uptake via 
scavenger receptors is not induced by the peptide itself, but requires the net 
negative charge of the CPP-oligonucleotide (Ezzat et al. 2012; Lindberg et al. 
2013; Lindberg et al. 2015) or CPP-plasmid DNA nano complexes (Arukuusk 
et al. 2013b; Veiman et al. 2013). 
Although there have been rare implications of direct protein-CPP inter-
actions, the role of a specific receptor has yet to be discovered. Furthermore, 
perhaps membrane proteins play a role in the internalization of CPPs indirectly 
by affecting the membrane composition or fluidity. 
 
 
1.4.3 Lipids and sterols 
Cells are surrounded with a lipid bilayer, which together with proteins and 
carbohydrates form a protective barrier around the cell. Lipid bilayer consists of 
thousands of different types of lipids. Each lipid molecule is amphipathic, 
containing a polar hydrophilic head and two hydrophobic hydrocarbon tails. 
The length of the fatty acid tail can vary, but it is usually between 14 and 24 
carbon atoms. The eukaryotic plasma membrane is predominantly composed of 
glycerophospholipids, which contain a phosphate-carrying diacylglycerol linked 
to various head groups. A neutral lipid phosphatidylcholine constitutes over half 
of the lipids in the eukaryotic membrane. Another major lipid found in the 
plasma membrane is sphingomyelin, a lipid with a ceramide in its hydrophobic 
backbone. Similarly to phosphatidylcholine, sphingomyelin does not hold a net 
charge. Both lipids localize predominantly in the outer leaflet of the plasma 
membrane together with the carbohydrate-containing glycolipids; whereas the 
inner leaflet consists mainly of phosphatidylethanolamine and of a smaller 
amount of phosphatidylserine (PS). In addition, phosphatidylinositol localizes 
in minor quantities in the cytosolic part of the membrane, and together with PS 
they generate the negative charge of the inner leaflet of the plasma membrane 
due to their anionic head groups (reviewed in van Meer et al. 2008).  
The majority of CPPs are positively charged, which favours the electrostatic 
interactions with the negatively charged lipids. However, anionic lipid content 
in the plasma membrane is rather small, around 10%. Furthermore, only around 
2% of negatively charged lipids localize in the extracellular leaflet, decreasing 
the probability that the cellular uptake of CPPs is mainly mediated by anionic 
lipids. Nevertheless, the impact of anionic lipids cannot be neglected, since in 
some medical conditions negatively charged PS can be exposed on the cell 
surface (Zwaal et al. 2005), which favours the interactions with cationic CPPs. 
Furthermore, as suggested previously, interactions with negatively charged lipids 
may come into focus when CPPs are trapped in endosomes, since the late 
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endosome membrane normally contains more negatively charged lipids (Erazo-
Oliveras et al. 2012). Indeed, the central role of negatively charged PS in the 
membrane interaction and the subsequent internalization has been demonstrated 
for several occasions. Studies with model membrane systems demonstrated that 
anionic phosphatidylserine is essential for the translocation of Tat peptide 
(Ciobanasu et al. 2010). The finding was complemented by a study according to 
which the accumulation efficacy of arginine-rich CPPs was proportional to the 
anionic phospholipid content in the vesicle membrane and the lipid flip-flop 
caused by the peptide internalization (Swiecicki et al. 2014). Furthermore, the 
relocation of PS during CPPs internalization has been demonstrated also in the 
cell culture, where PS signal was detected at the peptide influx sites (Hirose et 
al. 2012).  
In general, the internalization of amphipathic CPPs, such as transportan, does 
potentially involve hydrophobic but not electrostatic interactions, since these 
peptides bind to neutral and anionic lipids with the similar affinity (Magzoub et 
al. 2001). Nevertheless, since these peptides contain also cationic amino acids, 
electrostatic interactions have been also shown to be involved in the insertion of 
the peptide into the membrane (Anko et al. 2012). According to the same study, 
PepFect3 and PepFect6, interact more avidly with the neutral membranes 
compared with the parent peptide TP10 due to the stearyl moiety, indicating that 
interactions are predominantly hydrophobic. 
Besides phospholipids, membranes of animal cells are enriched with 
cholesterol, which constitutes around 20% of the lipids by weight (Alberts et al. 
2013). By localizing in-between phospholipids in both membrane leaflets, 
cholesterol affects the membrane fluidity, making the membrane more rigid and 
less permeable (Alberts et al. 2013). For this reason, cholesterol potentially has 
an inhibitory effect on the direct penetration of CPPs. This view is supported by 
a study showing that the high cholesterol content prevents the insertion of 
transportan into the lipid membrane. Furthermore, peptide-membrane inter-
actions were shown to take place in the more fluid and cholesterol-poor mem-
brane regions (Arsov et al. 2008). In light of these results, penetration of CPP 
through the membrane can happen more easily in endosomes, as cholesterol 
content in the late endosomal membrane is much lower compared with the 
plasma membrane (van Meer et al. 2008). Furthermore, depletion of cholesterol 
from the plasma membrane has been shown to promote the cellular uptake of 
octa-arginine (Fretz et al. 2007) and also penetratin, although at higher con-
centrations (Bechara et al. 2015). On the other hand, as cholesterol is one of the 
main lipid raft components, its depletion has been shown to decrease the 
internalization of some CPPs, indicating that these peptides internalize via raft-
dependent endocytosis (Kaplan et al. 2005). 
In addition to cholesterol, sphingolipids influence the membrane rigidity. 
One of the major sphingolipids in mammalian cells is sphingomyelin, which is 
localized mainly in the extracellular leaflet of the plasma membrane (van Meer et 
al. 2008; Alberts et al. 2013). Sphingomyelin is hydrolysed by sphingomyelinase 
into ceramide, a bioactive lipid that regulates several cell signalling pathways 
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(Grassmé et al. 2007; Hannun and Obeid 2008). Furthermore, ceramide induces 
lipid reorganization, including displacement of cholesterol and destabilization 
of lipid ordered phases (Megha and London 2004; Yu et al. 2005), and has also 
been proposed to induce membrane curvature in model membranes (Holopainen 
et al. 2000). Moreover, similarly to cholesterol, ceramide can form rigid plat-
forms in membranes (Megha and London 2004). Recent studies have reported 
the role of ceramide in the internalization of CPPs. The borderlines between 
CPP-induced ceramide-rich regions and fluid membrane domains have been 
proposed to be the sites for translocation of arginine-rich CPPs (Verdurmen et 
al. 2010). The indirect role of ceramide was demonstrated for the cellular entry 
of penetratin, where ceramide formation promoted GAG-clustering, leading to 
higher uptake (Bechara et al. 2015). 
 
1.4.3.1 Lipid rafts 
The lipid raft concept was proposed in 1997 as a hypothesis that lipids, choles-
terol and proteins form nanoscale platforms in the plasma membrane that are 
involved in the membrane transport and signalling (Simons and Ikonen 1997). 
Lipid rafts or membrane microdomains are formed from cholesterol, glycosylated 
sphingolipids, lipids with saturated acyl chains and certain saturated lipid-
anchored or transmembrane proteins (Hancock 2006; Sezgin et al. 2012). It is 
thought that these rafts are submicroscopic and highly dynamic, associating and 
disassociating continuously (Sengupta et al. 2008; Lingwood and Simons 2010; 
Simons and Gerl 2010). In physiological conditions, rafts have been almost 
impossible to detect without any external influence, such as cross-linking (Simons 
and Gerl 2010) and are therefore usually examined in artificial or plasma 
membrane-derived vesicles (Baumgart et al. 2007; Lingwood et al. 2008; 
Simons and Gerl 2010). Not long ago, a first cell-based study provided direct 
evidence of plasma membrane rafts (Owen et al. 2012). Furthermore, most of 
the membrane of cells was shown to be highly ordered, and only about 24% of 
the cell surface is occupied by the disordered lipid domains. However, because 
of their dynamic properties, and thus, complicated analysis there is a poor 
understanding about their properties and regulation. Therefore it is not clear 
whether membrane rafts facilitate or interfere with the internalization of CPPs. 
 
 
1.5 Model membrane systems and plasma  
membrane vesicles 
1.5.1 Model membrane systems 
The plasma membrane of a eukaryotic cell is very complex and dynamic, which 
complicates the detailed analysis of the interactions between specific membrane 
constituents and CPPs. Furthermore, the continuous flow of endocytosis and 
exocytosis makes it difficult to distinguish whether CPPs internalize via 
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endocytosis, translocation or both. Therefore, simplified model membrane 
systems have become invaluable tools for studying the interactions of CPPs 
with the membrane and its constituents. Moreover, these lipid models enable to 
focus solely on cellular energy-independent internalization mechanisms (Anko 
et al. 2012; Maniti et al. 2012; Katayama et al. 2013). 
Although a variety of different cell-free models are available, including lipid 
monolayers, supported lipid bilayers and vesicles of different composition and 
size, the most frequently used artificial membranes to study CPPs are large- and 
giant unilamellar vesicles (LUVs and GUVs). More natural systems that are 
used for CPP studies are giant plasma membrane vesicles (GPMVs) and plasma 
membrane spheres (PMS), which mimic the native plasma membrane of cells 
most closely. 
 
 
1.5.1.1 Artificial membrane systems 
Artificial model membrane systems, such as large and giant unilamellar 
vesicles, can be prepared by using several methods that include hydration of 
lipid films, electroformation, the fusion of smaller vesicles, etc. (Walde et al. 
2010). Lipids that are used to form the vesicles are present in biological mem-
branes, such as POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), 
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) and others. These vesicles 
can be supplemented with cholesterol and sphingomyelin (Walde et al. 2010) or 
even proteins (Chan and Boxer 2007). LUVs have usually diameters of about 
100 nm or less, while GUVs` diameter may range from 1 up to 100 of micro-
meters (Chan and Boxer 2007; Walde et al. 2010). LUVs are utilized less often 
than GUVs for studying CPPs, because of their smaller size and therefore more 
difficult analysis by conventional microscopy. Defined composition of GUVs 
and LUVs makes them good models to study the role of individual membrane 
constituents under controlled conditions. However, on the other hand, these 
models are severely limited in mimicking the complexity of a native lipid 
membrane. 
 
1.5.1.2 Giant plasma membrane vesicles 
GUVs, LUVs and other artificial membrane systems can be very useful, but are 
often too simplified to imitate the complexity of the native plasma membrane. 
Plasma membrane spheres (PMS) and giant plasma membrane vesicles 
(GPMVs), derived from the cell membrane, mimic the native plasma membrane 
the most. PMS are obtained using a hypotonic buffer that induces cell swelling 
and leads to the formation of vesicles (Lingwood et al. 2008). Similarly to 
PMS, GPMVs are derived from the plasma membrane and are therefore nearly 
identical to the latter (Keller et al. 2009). These giant vesicles are released from 
the membrane via the process termed blebbing. Blebbing is a very common 
phenomenon, as it is required for cytokinesis, cell migration, apoptosis and it is 
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one of the defence mechanisms of an injured cell (Charras et al. 2008; 
Babiychuk et al. 2011). During blebbing, the plasma membrane is dissociated 
from the actin cortex and that part of the membrane will bud outward. This can 
lead to a vesicle formation, but usually blebs are retracted. The formation of 
these kinds of blebs can be also evoked by treatment of the cells with various 
chemicals. The blebs induced by chemicals are released from the membrane and 
cannot retract. Two basic protocols are mainly used for inducing GPMVs and 
both of these involve treatment of cells with a buffer that is rich in calcium ions. 
The first method evokes blebs using a buffer supplemented with minute 
amounts of dithiothreitol (DTT) and formaldehyde (FA) (Scott 1976; Holowka 
and Baird 1983). DTT affects the proteins by reducing disulfide bridges between 
cysteine residues, while formaldehyde cross-links and modifies sulfhydryl and 
amino groups. In the second method DTT and FA are substituted with  
N-ethylmaleimide (NEM). NEM forms irreversible covalent bonds with 
sulfhydryl moieties in proteins, and blocks these groups. Unlike FA, NEM does 
not cross-link sulfhydryl groups, and is therefore considered to be a somewhat 
milder treatment for vesicle formation compared with the DTT/FA method. 
Chemical treatment and modification of proteins trigger an influx of calcium 
ions into the cells. Since calcium regulates a vast number of processes in cells, 
it is difficult to pinpoint, which of these are actually influenced by elevated Ca2+ 
in the cytosol that result in the formation of vesicles. However, it is known that 
an increased concentration of calcium ions is essentially the key to the formation 
of GPMVs (Keller et al. 2009). It is suggested that elevated concentration of 
calcium in cell cytosol activates Ca2+ dependent enzymes - phospholipase C and 
scramblases. The latter induces lipid flip-flop, and at high calcium concen-
trations, it destroys the plasma membrane asymmetry, while phospholipase C 
degrades phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]. PI(4,5)P2-rich micro-
domains concentrate proteins that anchor actin cytoskeleton to the plasma 
membrane; and degradation of PI(4,5)P2 leads to membrane destabilization. 
This triggers the budding of the plasma membrane and the intracellular pressure 
induces an influx of the cytoplasm into the forming vesicle, which can lead to 
the release of the GPMVs from cells (Keller et al. 2009) (Figure 2). 
Although, GPMVs that are formed using chemicals are very similar to the 
native plasma membrane of cells, there are still a few factors to be considered 
when using this model membrane system. The major changes in the membrane 
of GPMVs are the covalent modifications – cross-linking and blocking of the 
sulfhydryl groups by the chemicals that are used to induce the vesicles. Covalent 
modifications with DTT and FA treatment can lead to the relocation of some 
proteins from the raft membrane phase (Levental et al. 2010). The alternative 
method for the preparation of vesicles with NEM that avoids cross-linking of 
proteins is therefore considered to be more “natural” (Levental et al. 2011). The 
second difference between cells and GPMVs is the partial loss of the membrane 
asymmetry that includes translocation of phosphatidylserine to the outer leaflet 
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Figure 2. The potential mechanism of giant plasma membrane vesicle formation. 
Chemical treatment and modification of proteins trigger an influx of calcium ions into 
the cells. Elevated Ca2+ in the cytosol activates Ca2+ dependent enzymes, which induce 
lipid flip-flop and destroy the plasma membrane asymmetry. The activation of calcium-
dependent enzymes leads also to the degradation of connections between the actin 
cytoskeleton and the plasma membrane. This triggers the budding of the plasma 
membrane and the release of vesicles.  
 
of the membrane. Phosphatidylserine is found in the intracellular leaflet of the 
plasma membrane in live cells and it is exposed on the extracellular side only in 
certain physiological conditions, including apoptosis (Keller et al. 2009). Phos-
phatidylserine has a negative charge and therefore interactions with positively 
charged CPPs and consecutive effect to the internalization cannot be ruled out. 
Despite these limitations, the high similarity with the plasma membrane provides 
several advantages of GPMVs, compared with other model membrane systems. 
Because GPMVs are derived from the cells, the lipids, proteins and polysac-
charides contained in these structures originate from natural plasma membrane 
(Scott 1976; Scott et al. 1979; Bauer et al. 2009). The interior of the vesicle is 
filled with the cytoplasm and it contains RNA (Åmand et al. 2011), however, 
GPMVs lack organelles and actin filaments (Baumgart et al. 2007; Keller et al. 
2009). Thus, GPMVs lack cellular energy-driven processes, including endo-
cytosis. The absence of endocytosis is a great advantage of this system over cells, 
because it allows to only focus on translocation of CPPs without employing endo-
cytosis inhibitors, which could have nonspecific effects on the internalization of 
the peptides. Moreover, unlike cells with a continuous flow of different processes, 
(e.g. changes in membrane composition, vesicle trafficking, active interactions, 
signalling networks, enzyme activity), the composition of GPMVs remains 
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constant, providing the opportunity to study the interactions and internalization 
mechanisms of CPPs under stable experimental conditions. 
 
1.5.1.3 Liquid ordered- and disordered membrane phases 
Under certain conditions, lipid nanodomains in GPMV membrane coalesce and 
form two segregated membrane phases: liquid-disordered (Ld) and liquid-
ordered (Lo) lipid phase (Baumgart et al. 2007; Sengupta et al. 2008). The latter 
is considered to resemble membrane rafts of the cells (Hancock 2006; Simons 
and Gerl 2010). Similarly to the membrane rafts, tightly packed Lo phase is rich 
in cholesterol and sphingolipids, contains phospholipids with long saturated 
acyl chains; and it is therefore often referred to as raft phase also in GPMVs 
(Hancock 2006; Sengupta et al. 2008; Levental et al. 2010). In contrast, less 
densely packed and more dynamic Ld phase mainly consists of unsaturated 
glycerophospholipids (Sengupta et al. 2008; Levental et al. 2011). Similar lipid 
domain separation can be induced also in GUVs, if the lipid mixture contains 
sterols and/or saturated lipids, especially sphingolipids (Sezgin et al. 2012). The 
segregated lipid domains in GPMVs can be specifically tagged with probes, for 
example with cholera toxin subunit B, which binds to the ganglioside GM1 that 
is a typical resident of the raft phase (Baumgart et al. 2007; Sengupta et al. 
2008); and annexin V, which binds to phosphatidylserine in the Ld domain 
(Johnson et al. 2010). Laurdan is also often used, and can be utilized to analyze 
the extent of lipid packing (Kaiser et al. 2009). Segregation of phases in 
GPMVs is determined by the temperature – at 10 °C, almost all DTT/FA-
induced vesicles undergo phase separation, whereas increased temperatures lead 
to the decreased Lo/Ld phase coexistence (Levental et al. 2009). The average 
miscibility transition temperature and the abundance of the phases are strongly 
dependent on the cholesterol content of the vesicles. Modulation of the 
cholesterol amount in GPMVs revealed that the higher concentration of 
cholesterol led to the disappearance of disordered lipid phase and decreased 
miscibility transition temperatures. The opposite results were obtained when the 
cholesterol was depleted from GPMVs (Levental et al. 2009). It was recently 
shown that temperature of phase separation depends also on the density of the 
cells – GPMVs formed from densely plated cells can have lower phase transition 
temperatures. The lower phase transition temperature also characterizes vesicles 
isolated from cells that have been serum-starved, or from cells that are under-
going apoptosis (Gray et al. 2015). The phase separation temperature is also 
dependent on the induction method of the vesicles. Coexisting lipid phases can 
be detected around 18 °C if vesicles are induced by DTT and paraformaldehyde 
(PFA), while the domains in NEM vesicles were shown to be smaller and phase 
segregation took place around 10 °C (Levental et al. 2011). The higher 
temperature for the segregation of lipid phases is caused by combined activity 
of DTT and PFA and does not occur when the chemicals are used alone. The 
cross-linking and reducing activity of PFA and DTT, respectively, do not 
elevate the phase separation temperature and it is not caused by the protein 
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depalmitoylation by DTT. Although PFA, which is a cross-linking agent, could 
be expected to increase the order in vesicles, the enhanced domain stability was 
strongly dependent on the DTT concentration (Levental et al. 2011). In terms of 
phase separation, the vesicles induced by NEM treatment are considered to be 
more “natural” and reflective of the plasma membrane of mammalian cells. In 
phase-separated GPMVs, the majority of proteins localize in the same lipid 
microdomain than in living cells (Baumgart et al. 2007; Sengupta et al. 2008; 
Johnson et al. 2010). For example, GPI-anchored proteins localize preferen-
tially into the Lo phase in GPMVs (Baumgart et al. 2007; Sengupta et al. 2008) 
and many transmembrane proteins were found to reside in Ld lipid phase 
(Sengupta et al. 2008). Furthermore, it was shown that palmitoylation is re-
quired for transmembrane proteins to localize into raft-phase (Levental et al. 
2010). 
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2. AIMS OF THE STUDY 
CPPs internalize into cells via different modes of endocytosis and direct 
translocation through the cell membrane. While endocytic pathways have been 
well described in the cellular uptake of CPPs, the energy-independent direct 
crossing of the plasma membrane has still remained elusive. Furthermore, the 
understanding of the exact role of the cell surface molecules mediating the direct 
translocation is still controversial; and it is not fully understood how the mem-
brane composition affects the translocation through the plasma- and endosomal 
membrane. Our aim was to focus on the direct translocation of CPPs by using a 
model membrane system that is devoid of endocytosis, but closely resembles 
the plasma membrane by its composition. The main goal of this thesis was to 
provide information about membrane lipid dynamics and the molecular partners 
which facilitate the penetration of several widely known CPPs through the 
biological membranes. 
 
The specific objectives of the current study were: 
– to define the membrane subdomains that favour or inhibit the direct cellular 
entry of CPPs; more precisely, to analyse the impact of cholesterol and 
ceramide on the translocation of CPPs across biomembranes (Paper I and II). 
– to assess whether plasma membrane proteins are required for the penetration 
of CPPs through the biological membranes (Paper II). 
– to analyse the role of cell surface glycans, in particular, glycosaminoglycans, 
in the translocation process of CPPs (Paper III).  
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3. METHODOLOGICAL CONSIDERATIONS 
Detailed information about the methods used in the studies can be found in the 
included articles and only a brief rationale for chosen methodological approaches 
and summary of the relevant theoretical background is presented here. 
 
 
3.1 Cell-penetrating peptides 
Throughout the studies, 6 widely known CPPs were examined, which varied in 
their sequence and physicochemical properties. The features of the peptides are 
described in more detail in the literature overview, and their sequence and classi-
fication are presented in Table 1. Briefly, nona-arginine (Arg9) and Tat peptide 
(pTat) belong to a class of cationic arginine-rich CPPs, which were among the 
first CPPs discovered and are still the most frequently used (Vives et al. 1997; 
Mitchell et al. 2000). Primary amphipathic CPPs, transportan (TP) and its trun-
cated analogue TP10, were among the first chimeric peptides designed as cellular 
delivery vectors (Pooga et al. 1998; Soomets et al. 2000). A well-studied penet-
ratin (pAntp) and a model amphipathic peptide, MAP were chosen to represent 
the secondary amphipathic CPPs. All six peptides were used in Paper I to study 
their direct translocation through the biological membrane and their lipid-phase 
preference. Dependence of the peptide internalization on the membrane 
composition and the specific role of cholesterol was analysed in Paper II. Two 
representatives of amphipathic (TP and TP10), and two arginine-rich CPPs 
(Arg9 and pTat) were chosen for further studies to examine the mechanisms and 
specific membrane components that are involved in the direct translocation 
(Paper II and Paper III). 
 
 
3.2 Cell cultures 
Altogether, five cell lines were used to induce giant plasma membrane vesicles, 
which were utilized in the experiments described in this thesis. Rat basophilic 
leukemia RBL-2H3 (RBL) cells were used in experiments conducted in the 
Paper I and II. RBL cells were chosen based on the initial protocol for pre-
paration of the vesicles (Holowka and Baird 1983). Furthermore, the detach-
ment of the vesicles from the plasma membrane of these cells is more efficient 
than in other cell lines, including human cervical carcinoma cell line HeLa, 
which was used as a control in the Paper I. 
Additionally, three different types of Chinese hamster ovary (CHO) cell 
lines were utilized. The wild-type CHO-K1 cells (WT) were used in paper II 
and III. In paper II, GPMVs were derived from CHO cells but not from RBL cells 
in order to study the impact of ceramide on the direct translocation of CPPs, 
because RBL cells contain a small amount of ceramide in the plasma membrane. 
In paper III, CHO glycosaminoglycan (GAG) mutant cell lines were utilized to 
39 
study the effects of different GAGs in the direct translocation process of CPPs. 
For this purpose, GAG-deficient CHO pgsA-745 cells (GAGneg) and heparan 
sulfate-deficient CHO pgsD-677 cells (HSneg) were employed. CHO pgsA-745 
cells are deficient in xylosyltransferase, which is a key enzyme in the synthesis 
of proteoglycans, and therefore these cells lack GAGs on the cell surface (Esko 
et al. 1985). However, CHO pgsA-745 cells still contain hyaluronic acid on the 
plasma membrane, because it is synthesized at the cell membrane (Prehm 1983). 
CHO pgsD-677 lack only HS, due to a defect in N-acetylglucosaminyltrans-
ferase and glucuronyltransferase, which are required for heparan sulfate 
synthesis. However, chondroitin sulfates (CS) are three-fold overexpressed in 
HSneg cells compared with the WT CHO cell line (Lidholt et al. 1992).  
 
 
3.3 Giant plasma membrane vesicles 
The plasma membrane of the eukaryotic cell is highly complex and dynamic, 
and it is continuously involved in various processes, which also cause changes 
in the composition of the plasma membrane. Thus, studying the specific 
interactions and membrane composition in the translocation of CPPs using cells 
is complicated. Furthermore, in order to examine the direct translocation in the 
cell culture, endocytosis has to be blocked either by low temperature or a set of 
endocytosis inhibitors; which both can have a substantial effect on the mem-
brane interactions of CPPs. To overcome these major drawbacks, many model 
membrane systems have been introduced, such as giant unilamellar vesicles. 
However, since they contain only a few types of lipids and usually no protein or 
carbohydrates, these systems can be overly simplified to study the internaliza-
tion of CPPs. Therefore, throughout the studies, we have used cell-derived giant 
plasma membrane vesicles (GPMVs), which have the advantages of the model 
membranes, such as the stable composition and lack of endocytosis, allowing us 
to focus solely on the translocation mechanism. At the same time their mem-
brane composition resembles closely that of a native plasma membrane of cells. 
Furthermore, in GPMVs, the lipid phases segregate, which allowed us to examine 
the role of the lipid “rafts” in the translocation of CPPs. 
Giant plasma membrane vesicles (GPMVs) were prepared by using two 
standard protocols (Scott 1976; Holowka and Baird 1983; Baumgart et al. 2007). 
According to the first method, the cells are treated with a calcium-rich buffer 
supplemented with dithiothreitol (DTT) and formaldehyde (FA) (Holowka and 
Baird 1983). The second method also includes treating the cells with calcium-
rich buffer; however, DTT/FA are substituted with N-ethylmaleimide (NEM) 
(Holowka and Baird 1983). Initially, in Paper I, we used DTT/FA for the 
preparation of the vesicles. Protocol with NEM was introduced later (Paper II), 
after the discovery that DTT/FA method could cause crosslinking of proteins 
and NEM was considered a somewhat milder inducer of blebbing (Levental et 
al. 2010). However, since we could not prepare a sufficient number of GPMVs 
from CHO cells by NEM treatment, we returned to DTT/FA for inducing 
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vesicles from CHO cells in paper II and paper III. The integrity of the vesicles 
was verified by incubating GPMVs with the peptides that are classified as non-
CPPs: Perforin (82–96) (QRHVTRAKVSSTEAVAR, charge: +3) and a peptide 
from C-terminus of β1 adrenergic receptor, CSSLDEPGRGGFSSESKV, 
charge: −1); as well as with polysaccharide dextran (Mw 2–3 kDa), none of 
which was able to penetrate the membrane of GPMVs. 
 
 
3.4 Visualization and quantification of the direct 
translocation by confocal microscopy and flow cytometry 
Confocal laser scanning microscopy (CLSM) was used in all three papers to 
analyse the interactions of CPPs with the membrane of vesicles, as well as to 
quantify the accumulation of the peptides inside the GPMVs. Although confocal 
microscopy provides a good estimate of the internalization of CPPs, fluorescence-
activated cell sorting (FACS) was used in parallel in order to acquire quantitative 
data from a high number of individual GPMVs. Furthermore, FACS enables to 
examine the kinetics of the interactions and internalization of CPPs immediately 
after addition of CPPs into medium containing GPMVs. 
 
 
3.4.1 Studying the direct translocation of CPPs into GPMVs and 
preferential accumulation in membrane subdomains 
Throughout the studies, we examined the accumulation efficacies of the CPPs 
by using peptides labelled with fluorescein, and recording images at different 
confocal planes to obtain images at different levels of the vesicles by CLSM. 
In order to assess the formation of pores in the membrane of GPMVs during 
the translocation of CPPs, the efflux of the peptides was examined. First, the 
vesicles were immobilized on the glass coverslip and loaded with CPPs, then 
unbound peptides were removed, and the efflux of CPPs from GPMVs was 
estimated by the decrease in fluorescence intensity by confocal microscopy.  
At lower temperatures (below 10 °C), the membrane of the vesicles undergoes 
lipid phase separation in the majority of GPMVs, where the rigid liquid-ordered 
(Lo) and more dynamic liquid-disordered (Ld) membrane phase segregate. These 
membrane domains were visualised with fluorescently labelled cholera toxin 
subunit B, which binds to the ganglioside GM1 that localizes in the liquid-
ordered phase (Baumgart et al. 2007; Sengupta et al. 2008); and annexin V, 
which binds to the phosphatidylserine in the Ld domain (Johnson et al. 2010). 
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3.4.2 Studying the role of specific membrane constituents  
in the direct translocation of CPPs across membranes 
In the paper I, we discovered that besides efficient accumulation into the lumen 
of the vesicles, amphipathic CPPs accumulated in the Ld regions of the membrane 
that has low cholesterol concentration (Simons and Gerl 2010). Thus, in Paper 
II, we further investigated whether the internalization of the CPPs is influenced 
by the cholesterol concentration in the membrane of vesicles. For this purpose, 
we depleted cholesterol from the membrane of GPMVs with methyl-β-
cyclodextrin (MCD) to increase the proportion of Ld domains in GPMVs. We 
also reversed the situation by enhancing the cholesterol concentration in the 
membrane of vesicles using MCD-cholesterol complex (Watkins et al. 2009), 
increasing the proportion of rigid and raft-like membrane. The respective 
decrease and increase in the cholesterol concentration was estimated using a 
fluorescent macrolide, filipin, and analysed by FACS. 
Similarly to cholesterol, ceramide can generate highly ordered platforms in 
membranes (Megha and London 2004). Therefore, in Paper II, we proceeded by 
introducing ceramide in the membrane of GPMVs hydrolysing sphingomyelin 
into ceramide with sphingomyelinase. The anti-ceramide antibody was used for 
corroborating the emergence of ceramide-rich regions in the membrane of 
GPMVs. In Paper II, we also assessed the potential role of proteins in penetration 
of CPPs across the limiting membrane of GPMVs. Thus, we degraded the 
membrane proteins on the surface of GPMVs with trypsin and analyzed the 
internalization efficacy of CPPs by confocal microscopy. 
In paper III, we continued with the identification of the membrane con-
stituents that facilitate the direct translocation of CPPs across membranes and 
focused on the role of specific cell surface polysaccharides, namely glycosa-
minoglycans (GAGs). For this purpose, GAG- and heparan sulfate-deficient cell 
lines were utilized for the preparation of GPMVs and the yield of CPP accu-
mulation was examined by CLSM and FACS analysis. To confirm the results, 
the particular GAGs were degraded by treating the vesicles with hyaluronidase 
VIII, heparinase III or chondroitinase ABC that remove hyaluronic acid, 
heparan sulfates; chondroitin and dermatan sulfates, respectively. The effective-
ness of the removal of these GAGs upon enzyme treatment was confirmed by 
using fluorescently labelled carbohydrate-binding proteins – lectins. More 
specifically, we applied wheat germ agglutinin (WGA), that binds to N-acetyl-
glucosamine residues, which are present in heparan sulfates, hyaluronic acids, 
keratan sulfates and sialic acids. Wisteria floribunda agglutinin (WFA) was 
harnessed for quantification of N-acetylgalactosamine residues, the constituent 
of chondroitin and dermatan sulfates. AutoQuant X3 was used for the quantitative 
analysis of the confocal microscopy images of the internalized CPPs in enzyme-
treated vesicles, as well as to measure the labelling of the membranes with 
lectins. 
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4. RESULTS AND DISCUSSION 
Direct translocation of CPPs across the plasma and/or endosomal membrane has 
been intensely studied since the discovery of CPPs. However, a detailed 
molecular understanding of the exact translocation mechanism and the potential 
role of specific binding partners have remained elusive for several reasons. 
Firstly, the direct translocation can be studied in cell cultures only when endo-
cytosis is blocked either by the pharmacological inhibitors, RNA interference or 
by low temperature. All of these factors may affect cellular processes and the 
properties of the plasma membrane. Additionally, low temperature can lead to 
the undervaluation of the internalization efficacies of CPPs, resulting from the 
decreased membrane dynamics that hinders the translocation. Although several 
model membrane systems have been used to overcome these limitations these 
systems fail to recapitulate the complexity of the native plasma membrane due 
to the presence of only a few lipid species in such membranes. Therefore, in 
order to study the mechanisms of direct penetration of CPPs, as well as the con-
comitant interactions with the membrane constituents, we utilized giant plasma 
membrane vesicles (GPMVs) that are devoid of endocytosis, and at the same 
time, closely resemble the native plasma membrane by its composition. By 
using GPMVs, we examined the interaction of CPPs with the membranes of 
variable composition to gain a detailed understanding of the specific molecular 
partners that are essential for the direct translocation of a number of widely 
known representatives of the cationic and amphipathic CPPs. 
 
 
4.1 CPPs translocate into the lumen of giant plasma 
membrane vesicles at low and high temperature (Paper I) 
We first assessed the translocation efficacy of the representatives of cationic 
(Arg9 and pTat) and amphipathic (pAntp, TP, TP10 and MAP) CPPs. All 
studied peptides were able to penetrate the membrane and also accumulated into 
the lumen of vesicles at room temperature. We also studied the internalization 
efficacy at low temperature that decreased the accumulation markedly. The 
inhibitory effect of the lower temperature is probably resulting from the fact that 
membrane becomes more solid or gel-like, which reduces the membrane penet-
ration of CPPs. 
When we examined the accumulation of CPPs into the vesicles, a distinct 
internalization pattern emerged for the two classes of CPPs: the signal of cationic 
CPPs was detected only from the interior of the vesicles, while all amphipathic 
CPPs also concentrated into the membrane of GPMVs. Thus, there is a clear 
correlation between the amphipathicity and the membrane affinity of CPPs.  
Another interesting finding was that after incubation of the vesicles with 
penetratin, we detected the appearance of smaller vesicles budding out from 
GPMVs derived from RBL cells. Similar effects have been later described when 
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the plasma membrane spheres were used: nona-arginine and amphipathic RW9 
induced outward budding of the membrane and the amphipathic peptide showed 
stronger bud-inducing activity (Maniti et al. 2014).  
To gain further insights into the internalization kinetics of the CPPs, we 
analysed the interactions of CPPs with GPMVs at different time points and con-
centrations (0.01–1 µM). Arginine-rich CPPs interacted with GPMVs within 
few minutes, followed by continuous accumulation, and reaching a plateau in 1h. 
Similar internalization profile was detected at all used CPP concentrations, and 
also at both, low (around 4 °C) and ambient temperature. However, the accu-
mulation efficacy into the vesicles at low temperature was markedly decreased 
compared with the room- and physiological temperature, as also noted above. 
On the contrary to Arg9 and pTat, the association of transportan with vesicles was 
more rapid, reaching the saturation plateau almost instantly at all concen-
trations. Furthermore, the incubation temperature had seemingly no impact on 
the translocation of TP. 
To obtain a better understanding of the actual mechanism behind the direct 
translocation, we further examined the pore-forming capability of the peptides. 
We reasoned that if the internalization would include the formation of a pore, 
we could detect the efflux of the peptide from the vesicles. However, no sub-
stantial leakage of the peptide could be observed, indicating that studied CPPs 
do not induce pores, at least not the permanent ones.  
 
 
4.2 Amphipathic CPPs preferentially accumulate into  
the lipid disordered membrane phase (Paper I) 
At low temperature, the membrane of GPMVs phase-segregates into liquid-
disordered (Ld) and liquid-ordered (Lo) lipid phase (Baumgart et al. 2007; 
Sengupta et al. 2008). The latter is thought to resemble membrane rafts of the 
cells (Hancock 2006; Simons and Gerl 2010), which are cholesterol- and sphin-
golipid-rich and contain phospholipids with long saturated acyl chains (Han-
cock 2006; Sengupta et al. 2008; Simons and Gerl 2010). On the contrary, Ld 
phase mainly consists of unsaturated glycerophospholipids and is thus more 
dynamic (Sengupta et al. 2008; Levental et al. 2011). We labelled the respective 
liquid phases with the cholera toxin B subunit and annexin V. Upon incubation 
of these phase markers with CPPs, all amphipathic peptides co-localized with 
annexin V into the Ld phase, demonstrating that these peptides have a higher 
affinity towards more fluid membrane regions. No accumulation of the peptides 
was seen in the Lo domain, indicating that these “raft” like regions are not pre-
ferable binding sites for amphipathic CPPs. It is worth mentioning that during 
the formation of GPMVs a fraction of phosphatidylserine (PS) relocates into the 
outer leaflet of the vesicles, while in intact cells, it is predominantly localized in 
the intracellular leaflet of the plasma membrane. PS is a negatively charged 
lipid that has been shown to promote the internalization of CPPs (Ciobanasu et 
al. 2010). Furthermore, it localizes in the disordered membrane phase, and 
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therefore could be a potential binding partner for CPPs. However, we did not 
find a correlation between the intensity of annexin-labelling (the concentration 
of PS) and accumulation of CPPs in GPMVs (unpublished data). Probably the 
presence of PS does not induce localization of amphipathic CPPs to Ld regions 
of GPMVs. 
Consistent with our findings, the binding of penetratin and its analogues to 
the model lipid membranes was markedly decreased when the limiting mem-
brane of vesicles was enriched with cholesterol, which induces higher “order” 
in the membrane (Christiaens et al. 2002). Similarly, by using artificial lipo-
somes with different degree of lipid packing, it was demonstrated that Cys-TP 
induced lipid rearrangements and membrane permeabilization in vesicles with 
more dynamic membrane, whereas in liposomes with higher rigidity and 
cholesterol content the reorganization of lipids did not occur (Arsov et al. 
2008). Based on published and our own results, it is possible to conclude that 
the fluidity of the membrane greatly affects the membrane activity of 
amphipathic CPPs. 
 
 
4.3 Cholesterol inhibits the internalization of CPPs  
(Paper II) 
Since amphipathic CPPs preferentially accumulated into the liquid-disordered 
membrane regions, we reasoned that the phase preference could be the result of 
the higher fluidity of the Ld domain; and on the contrary, tighter packing of the 
Lo phase abolishes the interactions. One of the main factors triggering the 
formation of ordered or “raft” phase is cholesterol, which could modulate the 
penetration of CPPs by packing lipids in membranes “more densely”. In order 
to examine the role of membrane fluidity and the effect of cholesterol in 
particular, we removed the latter from the membrane of GPMVs, which led to 
about four-fold decrease in the signal of cholesterol-binding macrolide filipin. 
The decrease in the cholesterol content promoted the internalization of Arg9, 
pTat and pAntp predominantly into the small population of vesicles, that other-
wise were not as prone for the uptake of CPP as compared with the majority of 
the vesicles. On the other hand, the accumulation of transportans and MAP was 
seemingly unaffected by the lower degree of cholesterol. In order to gain further 
insights into the membrane fluidity-dependent internalization, we proceeded by 
reversing the experiment and added cholesterol into the membrane of the vesicles. 
We detected almost a two-fold increase in the filipin staining, confirming that the 
membrane of GPMVs was enriched with cholesterol. The addition of cholesterol 
resulted in a slight increase in the number of vesicles that contained Arg9, pTat 
and pAntp at a very low level. Probably the high proportion of densely packed 
membrane subdomains does not abolish the translocation of Arg9, pTat and 
pAntp into vesicles, but these subdomains are not the preferred areas for the 
internalization of cationic CPPs. The greatest impact of cholesterol on the 
translocation efficacy was detected in the case of transportans and MAP, which 
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showed a strong decrease in the accumulation into cholesterol-rich GPMVs. 
Thus, the results suggest that more rigid membrane areas interfere with the 
translocation of these peptides. Moreover, in untreated GPMVs the interaction 
is rapid, reaching the saturation plateau within 5 minutes; but in cholesterol-
enriched vesicles, we detected slower and gradual interaction with transportans 
and MAP. These results are in a good agreement with those described above, 
where we observed the preferential accumulation of the peptides into more 
dynamic membrane regions. Based on lipid phase preference and negative 
influence of cholesterol, it is feasible that the internalization of the studied pep-
tides, especially amphipathic CPPs, takes place preferentially at the less rigid and 
more dynamic disordered membrane subdomains. 
 
 
4.4 Ceramide promotes the translocation  
of arginine-rich CPPs and inhibits the internalization  
of amphipathic CPPs (Paper II) 
Since cholesterol had a substantial effect on the internalization ability of CPPs, 
we wanted to further assess the impact of membrane rigidity. Similarly to cho-
lesterol, ceramide can form highly ordered platforms in biomembranes (Megha 
and London 2004). We proceeded by analyzing the accumulation efficacy of two 
representatives of arginine-rich, Arg9 and pTat, and amphipathic, TP and TP10, 
CPPs into ceramide-rich GPMVs. Corroborating our previous results, we ob-
served nearly a 50% decrease in the internalization efficacy of both amphipathic 
CPPs into ceramide-rich GPMVs, confirming that the translocation of TP and 
TP10 is strongly dependent on membrane rigidity and the cellular entry is likely 
to take place at the sites of the plasma membrane that have higher fluidity. 
On the contrary, both arginine-rich CPPs displayed an increased membrane 
permeabilization into ceramide-rich vesicles. Prior to generation of ceramide in 
the membrane of GPMVs, the internalization of cationic CPPs is rather hetero-
geneous, and the accumulation of peptide greatly varies between vesicles. After 
ceramide formation, the number of vesicles that poorly internalized CPPs 
diminished. Thus, the results imply that ceramide is not a prerequisite for the 
translocation of arginine-rich CPPs across membranes, but it can greatly improve 
the membrane penetration of these peptides. Corroborating to our findings, 
Verdurmen et al. demonstrated that the borderlines between the ceramide-rich 
regions and fluid membrane domains are preferable sites for the translocation of 
arginine-rich CPPs (Verdurmen et al. 2010). 
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4.5 Plasma membrane proteins facilitate  
the internalization of arginine-rich CPPs (Paper II) 
The plasma membrane is heavily decorated with proteins that mediate a great 
number of cellular processes, including transport of macromolecules. Therefore, 
we next focused on the role of proteins in the direct translocation of CPPs. 
Upon degradation of proteins from the surface of GPMVs’ membrane, the 
accumulation of arginine-rich CPPs into vesicles was almost completely 
abolished, while the internalization of TP and TP10 was only slightly affected. 
The publications, showing the pivotal role of membrane receptors in the cellular 
entry of CPPs, have only recently begun to emerge (Tanaka et al. 2012; Pang et 
al. 2015). However, association with the receptor usually triggers the endocytic 
uptake, but not direct penetration (Tanaka et al. 2012; Pang et al. 2015). Never-
theless, protein components can also affect the translocation indirectly, e.g 
affecting the membrane organization, or contributing to the formation of mem-
brane lipid rafts (reviewed in Hancock 2006). Protein-dependent lipid raft sta-
bility is supported by our results, showing that after degradation of membrane 
proteins, lipid phases do not segregate so well even at low temperatures, indi-
cating permanent changes in the membrane microenvironment (unpublished 
data). This indirect effect of proteins on CPPs internalization can be explained 
by the membrane packing defects at the borderlines of raft regions and the rest 
of the membrane. Defects in the membrane organization could create the 
favourable environment for the direct translocation of CPPs, which also explains 
the increased penetration through the membrane that is rich in ceramide rafts. 
These “sites” might also decrease the energy that is needed for the penetration 
of highly charged molecule through the membrane. In addition, since the 
plasma membrane proteins are also capable of inducing curvature in the 
membrane (reviewed in Zimmerberg and Kozlov 2006), another possible 
explanation is that the translocation of the studied arginine-rich CPPs takes 
place due to the protein-induced membrane curvature. The detailed under-
standing of the exact role of proteins, and perhaps the involvement of a possible 
receptor, requires further studies. 
 
 
4.6 Glycosaminogycans mediate the direct translocation  
of amphipathic CPPs (Paper III) 
Before the cellular uptake of CPPs, the peptides are encountered by the long 
branches of highly negatively charged glycosaminoglycans (GAGs). Since the 
majority of the CPPs are positively charged, interactions with GAGs are very 
likely to occur. Although numerous studies have investigated the involvement 
of GAGs in the cellular uptake of CPPs, the results have remained contradic-
tory. In order to assess whether GAGs are involved in the direct penetration of 
CPPs, we utilized heparan sulfate- (HSneg) and GAG-deficient (GAGneg) CHO 
cell lines to prepare the GPMVs. To our surprise, accumulation of arginine-rich 
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CPPs into all three types of vesicles remained similar, suggesting that despite of 
the expected high affinity towards GAGs, these polysaccharides are not 
involved in the direct translocation of arginine-rich CPPs through the mem-
brane. In contrast, we detected almost 50 % decrease in the accumulation of TP 
into GAG-deficient vesicles. Similar results were obtained with TP10, although 
translocation of the peptide into GPMVs was affected to a slightly lower extent. 
The accumulation rate of all four peptides into HSneg vesicles was comparable to 
the translocation efficacy of WT GPMVs. Although in heparan sulfate-negative 
cell line, chondroitin sulfates are overexpressed at three times higher level, which 
could compensate the lack of HS, the obtained results still show only a negligible 
role of HS in the translocation of studied CPPs. Furthermore, although we show 
here that the direct translocation of amphipathic CPPs into GPMVs is strongly 
dependent on the presence of GAGs, still, in their absence, the accumulation of 
peptides into vesicles was not abolished completely. This could be resulting 
from the fact that GAGneg vesicles still contain hyaluronic acid polymers on their 
surface, which could also interact with CPPs and mediate their translocation. To 
confirm the results, we specifically degraded particular GAGs from the mem-
brane of the WT GPMVs using treatment with selective glycosidases. In con-
cordance with our results obtained with GAG- and HS-deficient vesicles, the 
internalization into vesicles that lacked specifically HS, CS and HA was equally 
efficient in the case of both arginine-rich CPPs, further indicating that the direct 
translocation is not specifically mediated by any of these GAGs. Also, mem-
brane-crossing of both amphipathic CPPs was greatly affected by the removal 
of HA confirming our previously obtained results. However, the internalization 
of the amphipathic CPPs into vesicles where HS and CS were degraded was not 
hindered, implying that the translocation is not specifically facilitated by those 
GAGs. Translocation of amphipathic CPPs is not specifically mediated by HA 
either, as the internalization was decreased in GAGneg cells, despite the presence 
of HA. On the other hand, the uptake was almost completely abolished when 
HA was degraded on the surface of GPMVs, which most likely results from the 
fact that with the removal of HA, other GAGs that are attached to HA are 
simultaneously removed. Thus, these results suggest that the interaction of 
amphipathic CPPs is not facilitated by a specific type of GAG, but rather the 
overall quantity of these polysaccharides is essential for their translocation. 
Numerous articles have reported on the key role of GAGs, especially HS, in 
the cellular uptake of highly cationic CPPs, such as Tat peptide and oligoarginines 
(Console et al. 2003; Fuchs and Raines 2004; Richard et al. 2005; Nakase et al. 
2007). Fewer studies have focused on the importance of GAGs in the internaliza-
tion of amphipathic peptides. As cationic CPPs carry a high positive charge and 
therefore have a strong affinity towards negatively charged GAGs, the logical 
conclusion is that the stronger electrostatic interactions are responsible for the 
more efficient internalization. In light of our results, this view is overly 
simplified, which is also supported by the studies showing that high affinity does 
not always correlate with the better cellular uptake of CPPs (Jiao et al. 2009; 
Verdurmen et al. 2013). Furthermore, hydrophobic interactions are highly 
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frequent between glycans and polypeptides, and can also involve aromatic 
residues and alkyl side chains of amino acids (Cummings and Esko 2009 ). The 
role of hydrophobic amino acids in GAG-binding and subsequent internaliza-
tion was also recently demonstrated for CPPs (Bechara et al. 2013). Never-
theless, the surface charge is an important parameter of glycosaminoglycans in 
binding to polypeptides (Varki et al. 2009). Furthermore, GAG-binding amino 
acid sequences in protein always contain positively charged amino acids, 
arginine and lysine (Esko and Linhardt 2009).  
Although we demonstrate here that the role of GAGs in the internalization of 
Arg9 and pTat is less significant, the involvement of glycans and also GAGs 
cannot be excluded altogether, since other glycans may compensate the lack of 
GAGs, in particular, when the arginine content in CPPs is higher. This assump-
tion was confirmed by a study demonstrating that when some GAGs are missing 
the internalization of the peptide with the highest arginine content is least 
affected (Åmand et al. 2012). This view is also supported by an earlier report, 
where Nakase et al. proposed that if HS is missing, pTat that has lower charge 
density than nona-arginine cannot bind to other GAGs, which have lower sulfate 
content compared with HS. Octa-arginine, in contrary, can compensate the 
absence of HS by associating with other GAGs and internalize even though HS 
are missing (Nakase et al. 2007). However, these findings were described for 
the endocytic uptake and might not apply for the direct translocation, since we 
did not observe differences in the GAG-dependent accumulation of Arg9 and 
pTat in GPMVs. Indeed, the consensus view of GAG-dependent cellular uptake 
of CPPs seems to support the notion that GAGs, and in particular heparan 
sulfate proteoglycans (HSPGs), mediate the endocytic internalization of several 
CPPs. This is not unexpected, as PGs can act as receptors at induction of 
endocytosis for the clearance of bound ligands (Esko et al. 2009). 
 
 
4.7 Transportan co-localizes in the membrane  
subdomains enriched with glycans (Paper III) 
Interestingly, using co-incubation of WGA and TP, we detected that these 
molecules co-localize in the same subdomains in the membrane of GPMVs. As 
WGA binds to sialic acids and to the N-acetylglucosamine residues, which are 
present in heparan sulfates, hyaluronic acids and keratan sulfates, TP probably 
also interacts with these glycans. Furthermore, after addition of TP to the 
suspension of GPMVs, the WGA nanoclusters assembled into microdomains in 
the membrane of vesicles. In principle, there are two plausible explanations for 
the appearance of TP-induced WGA microdomains. The first involves the 
reorganization in the membrane of vesicles by TP, which in turn induces the 
relocalization of GAGs. On the other hand, TP can cross-link GAGs and by this 
induce reorganization of lipids and formation of bigger GAG clusters. Both 
scenarios are substantiated by results published earlier: the first demonstrate 
reorganization of lipids by CPPs in the membrane of artificial vesicles and 
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plasma membrane spheres (Alves et al. 2009; Maniti et al. 2014). Later reports 
have demonstrated clustering of GAGs by various CPPs, including amphipathic 
peptides (Ziegler and Seelig 2011; Verdurmen et al. 2013). However, GAG-
clustering does not always correlate with the increased internalization efficacy 
of CPPs (Verdurmen et al. 2013). Although, in cells, such micro-scale lipid 
rearrangements are hindered by the actin cortex and are thus, unlikely to occur, 
the membrane reorganization during the direct translocation can still take place 
at a smaller scale. 
 
 
4.8 Discussion 
Taken together, the findings of this research provide novel insights into the 
translocation mechanism of CPPs across membranes and provide information 
about the putative partner molecules that facilitate efficient internalization. We 
first identified that all studied CPPs were able to penetrate and accumulate in 
the lumen of GPMVs. However, further investigations led to a division of studied 
CPPs into separate classes, based on their interactions with the membrane 
constituents and internalization. The first group comprises arginine-rich pTat 
and Arg9 that belong to a class of cationic-CPPs, whereas amphipathic CPPs, TP, 
TP10, MAP form the second group. Correlating well with its sequence – 
containing arginines, but also hydrophobic amino acids; pAntp falls in-between 
those two classes based on membrane interactions. 
Arginine-rich CPPs translocated efficiently into the lumen of GPMVs and 
unlike amphipathic CPPs, these did not accumulate in the membrane of the 
vesicles. The internalization efficacy of these peptides and pAntp was slightly 
enhanced when the membrane fluidity was increased. Furthermore, the 
accumulation of Arg9 and pTat into vesicles was greatly promoted upon the 
induction of ceramide in the membrane of GPMVs. Ceramide can induce 
membrane curvature (Holopainen et al. 2000), and as previously proposed, the 
borderlines between ceramide-rich regions and the rest of the membrane are the 
most permeable sites (Verdurmen et al. 2010), both of which favour the inter-
nalization of CPPs. The membrane permeabilization of highly charged mole-
cules is energetically disfavoured, and these membrane regions, with the defects 
in the arrangements of lipids, could lower the energy needed for the direct trans-
location. Our results also support this assumption as we demonstrated that 
degradation of proteins on the surface of GPMVs almost abolished the trans-
location of arginine-rich CPPs into the lumen of vesicles. Since proteins have a 
key role in organizing membrane rafts, the edges of these membrane areas can 
have lipid packing defects, similarly to the borderlines of ceramide-rich regions; 
and after the abolition of the rafts, the favourable “sites” for translocation of 
CPPs are also lost. The membrane-organizing effect of proteins was actually 
confirmed by our observation that after the degradation of proteins on the sur-
face of GPMVs, no lipid phase segregation was detected, even at low tempera-
tures, indicating permanent changes in membrane microenvironment. However, 
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we cannot rule out the potential role of a receptor protein in the membrane that 
facilitates the internalization of arginine-rich CPPs. Further analysis of the 
potential binding partners on the cell surface, revealed that GAGs are not 
essential for the direct translocation of arginine-rich CPPs. As noted above, 
unlike arginine-rich CPPs, amphipathic peptides MAP, TP, TP10 and pAntp 
also concentrated into the membrane of vesicles clearly implying that amphi-
pathicity strongly contributes to the membrane affinity. Furthermore, we identi-
fied that these peptides preferentially localized into liquid-disordered membrane 
regions, implying that translocation might take place from these more dynamic 
domains. To further confirm this notion, we modified the membrane compo-
sition of the vesicles to increase the proportion of a highly ordered “state” by the 
addition of cholesterol. This resulted in a dramatic decrease in the internalization 
efficacy of amphipathic CPPs (except pAntp), indicating that these peptides 
translocate through more dynamic membrane regions. Confirming these results, 
we demonstrated that after inducing the ceramide formation in GPMVs, and 
thereby creating rigid lipid platforms in the membrane of vesicles, accumulation 
of amphipathic CPPs in vesicles was strongly inhibited. Thus, it is reasonable to 
conclude that membrane regions with the higher fluidity are the preferential 
sites for the membrane insertion and subsequent internalization of studied 
amphipathic CPPs. This, in turn, implies that perhaps translocation of CPPs 
across membranes involves hydrophobic interactions with the lipids and lipid 
rearrangements that can favourably take place in these more dynamic membrane 
regions as it has been also previously suggested (Arsov et al. 2008). The 
analysis of the composition of the native plasma membrane demonstrates that 
most of it is in the ordered or “raft” phase, whereas only about 25% is in a 
disordered state (Owen et al. 2012). In light of this, the major part of the plasma 
membrane of the cells is not suitable for the translocation of amphipathic CPPs. 
Nevertheless, the studied peptides are still efficient CPPs, capable of pene-
trating the membrane, implying that although the entry into cells can take place 
only from a small area of the membrane, it is still sufficient for the efficient 
internalization. Our further focusing on the role of membrane proteins in the 
translocation of these peptides led to the conclusion that amphipathic CPPs can 
penetrate the membrane despite deficiency of protein motifs on the surface of 
GPMVs. Although we detected a slight decrease in the accumulation efficacy 
after protein degradation from the membrane of GPMVs, it probably resulted 
from the fact that during trypsin treatment, some proteoglycans were also 
removed. These proteoglycans carry GAGs, which have a vital role in the inter-
nalization of amphipathic CPPs that we hereinafter discuss. We further focused 
on the role of GAGs and also on their abundance in the translocation of CPPs, 
rather than on the contribution of specific proteoglycan, since one proteoglycan 
molecule (e.g syndecan-1) can carry a highly varying number of GAG chains. 
Moreover, the GAGs on the same proteoglycan can have different length and 
position of sulfate groups, therefore possessing a vast number of possible motifs 
in the structure (Esko et al. 2009), and leading to dissimilar affinity for CPPs. 
Although there have been only rare implications of the GAG-dependent cellular 
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uptake of amphipathic CPPs, we show that the accumulation efficacy into the 
GAG-deficient vesicles is markedly lower, and the internalization was almost 
completely abolished after the enzymatic degradation hyaluronic acid polymers 
on GPMVs. In addition, we demonstrate that the internalization of amphipathic 
CPPs in not dependent on a specific GAG type, but rather the overall amount of 
GAGs is essential. It is plausible, that these huge branched cell surface poly-
saccharides facilitate the accumulation of amphipathic CPPs into the close 
proximity of the membrane and also help to achieve high local concentration, 
which is needed for the subsequent reorganization of lipids in order to trans-
locate into vesicles/cells. Analogously, the high local concentration is a pre-
requisite for the membrane activity of antimicrobial peptides, which share many 
common features with the studied amphipathic CPPs (Melo et al. 2009). Thus, 
the high local peptide concentration provided by the GAGs is probably required 
for both, the antimicrobial and cell penetrating activity of the respective 
peptides. In support of this view, we demonstrated that TP localizes into the Ld 
regions of the membrane together with GAGs, and also TP might rearrange the 
membrane of GPMVs, by inducing the formation of big clusters of GAGs. 
Possibly the latter due to the electrostatic and hydrophobic “cross-linking” of 
GAGs by amphipathic CPPs and “pulling” these together to form microscopic 
Ld platforms. 
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SUMMARY 
The plasma membrane of cells is an impermeable barrier for the macro-
molecules, including agents with very high therapeutic and biotechnological 
potential, posing a major hurdle for their application. However, this bottleneck 
can be overcome by harnessing carrier systems for cellular delivery. The cell-
penetrating peptides (CPPs) form a class of efficient transport vehicles that 
represent short peptide sequences, generally consisting of 4–40 amino acids, 
and having the capacity to cross the cell membrane and promote the intra-
cellular delivery of various bioactive cargoes.  
Despite the remarkable progress in the general understanding, how CPPs 
operate on a cellular level, still the information about their specific binding 
partners, exact plasma membrane composition and the mechanisms of trans-
location through membranes have remained controversial. It is widely accepted 
that CPPs enter cells via different pathways of endocytosis and direct trans-
location through the plasma membrane. While the endocytosis mechanisms 
have been well described, the latter internalization mode has remained elusive 
so far. Therefore, in the current thesis, we focused on the role of several plasma 
membrane constitutes, as well as the specific membrane composition, essential 
for the translocation of CPPs across biomembranes. 
 
The main results of this study are as follows: 
• The representatives of cationic arginine-rich CPPs, Tat peptide and nona-
arginine, and amphipathic CPPs, penetratin, TP, TP10 and MAP, can pene-
trate the lipid bilayer derived from the plasma membrane of cells. Amphi-
pathic CPPs have higher affinity for the membrane compared with the 
arginine-rich CPPs, and associate with more dynamic membrane regions 
(Paper I). 
• Cholesterol and tightly packed raft-like membrane microdomains inhibit the 
translocation of CPPs, affecting more strongly the penetration of amphi-
pathic peptides (Paper II). 
• Ceramide interferes with the internalization of amphipathic CPPs, but pro-
motes the direct translocation of arginine-rich peptides (Paper II). 
• The proteins in the membrane of GPMVs are indispensable for the trans-
location of arginine-rich CPPs, whereas do not markedly contribute to the 
penetration of amphipathic peptides into vesicles (Paper II). 
• Cell surface glycosaminoglycans are essential for the membrane crossing of 
amphipathic CPPs. Translocation of amphipathic CPPs does not depend on a 
specific type of glycosaminoglycan, but rather on the overall amount of 
these polysaccharides. Glycosaminoglycans are not required for the 
penetration of arginine-rich CPPs across biomembranes (Paper III).  
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SUMMARY IN ESTONIAN 
Rakku sisenevate peptiidide membraani läbimise mehhanismid ja 
interaktsioonid plasmamembraani komponentidega  
Raku plasmamembraan ümbritseb ja kaitseb rakku ning on bioloogilistele 
molekulidele selektiivselt läbilaskev, olles ka barjääriks paljudele potentsiaal-
setele terapeutilise toimega ühenditele. Enamik bioaktiivseid ühendeid on suu-
red ja hüdrofiilsed ning seetõttu on takistatud nende rakkudesse pääsemine ja 
kasutamine ravimina. Et suurendada bioaktiivsete molekulide rakkudesse pääse-
mist, on kasutusele võetud erinevad transportsüsteemid. Ühed perspektiivsemad 
transportvektorid on 4–40 aminohappest koosnevad järjestused – rakku sise-
nevad peptiidid (RSP), mis on võimelised läbima bioloogilisi membraane ning 
vahendama erinevate bioaktiivsete ühendite transporti rakkudesse. 
RSP-de efektiivseks kasutamiseks biotehnoloogias ja meditsiinis on oluline 
mõista RSP-de membraani läbimise mehhanisme raku tasemel. Arvukad uurin-
gud on näidanud, et RSP-d liiguvad rakkude väliskeskkonnast tsütoplasmasse, 
kasutades erinevaid endotsütoosiradu või läbivad membraani raku energiast 
sõltumatult – translokatsiooni teel. Samas ei ole siiski seniajani üheselt selge, 
kuidas RSP-de translokatsioon molekulaarsete mehhanismide tasemel täpset 
aset leiab ning millised interaktsioonid RSP-de ja raku pinna erinevate kompo-
nentide vahel sisenemist soodustavad.  
Seetõttu oli käesoleva töö põhieesmärkideks uurida: 
• Millistest plasmamembraani piirkondadest toimub eelistatult RSP-de rakku-
desse sisenemine ja kuidas mõjutavad membraani läbimist selle erinevate 
omadustega lipiidide mikrodomeenid ning membraani komponendid koleste-
rool ja tseramiid. 
• Kas plasmamembraani valgud on funktsionaalselt olulised RSP-de trans-
lokeerumisel läbi bioloogilise membraani. 
• Kas ja millised raku pinna glükoosaminoglükaanid on vajalikud RSP-dele 
membraani läbimiseks. 
 
Rakumembraan on väga dünaamiline ja selle koostist mõjutavad katkematult 
toimivad rakulised protsessid, mistõttu on plasmamembraani erinevate koostis-
osade ja RSP-de vaheliste interaktsioonide uurimine rakkudes komplitseeritud. 
Lisaks toimuvad rakkudes pidevalt endotsütootilised protsessid, mis rasken-
davad arusaamist, kas RSP-de rakkudesse sisenemine toimub translokatsiooni, 
endotsütoosi või mõlema mehhanismi vahendusel. Seetõttu kasutati antud töös 
plasma membraani vesiikuleid (PMV-sid). PMV-d on ideaalne mudelsüsteem 
uurimaks translokatsiooni, kuna nendes vesiikulites on rakuenergiast sõltuvad 
protsessid k.a endotüstoos blokeeritud, võimaldades keskenduda vaid trans-
lokatsiooni uurimisele. Lisaks on vesiikulite membraan oma koostiselt äärmiselt 
sarnane rakkude plasmamembraaniga, andes võimaluse vaadelda RSP-de inter-
aktsioone erinevate membraanikomponentidega. Kasutades PMVsid uuriti kuut 
tuntud RSP-d, mis esindavad arginiinirikkaid (Arg9 ja Tat peptiid) ning amfi-
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paatseid (TP, TP10, penetratiin, MAP) peptiide. Kuna PMV-des võivad 
membraani erinevate omadustega lipiidsed vedelfaasid temperatuurist sõltuvalt 
lahkneda, siis iseloomustati esmalt RSP-de interaktsioone ja membraani läbimist-
lähtuvalt nendest mikropiirkondadest. Uurimuse tulemused näitasid, et amfi-
paatsetel peptiididel on kõrgem afiinsus membraani suhtes võrreldes arginiini-
rikaste RSP-dega ja et amfipaatsed RSP-d eelistavad seonduda dünaamilisema 
ning madalama korrapäraga lipiidifaasiga. Seetõttu võib eeldada, et ka nende 
RSP-de rakku sisenemine toimub sarnase iseloomuga membraanipiirkondade 
kaudu. Kuna kolesterool on oluline kõrgema korrapäraga lipiidifaaside moodustu-
miseks, kus see võimaldab fosfolipiidide tihedalt kokku pakkida, siis järgnevalt 
hinnati kolesterooli mõju RSP-de vesiikulitesse sisenemise efektiivsusele. Tule-
mustest selgus, et kolesterooli kõrgem kontsentratsioon membraanis vähendas 
kõikide uuritud RSP-de, ning eriti mõjusalt amfipaatsete peptiidide membraani 
läbimise efektiivsust. Seega võib järeldada, et kolesterooli lisamisel vesiikulite 
membraani suureneb selles tõenäoliselt korrastatud faasi osakaal ja RSP-dele 
vesiikulitesse sisenemiseks sobivate membraanipiirkondade pindala väheneb. 
Saadud tulemused kinnitasid meie hüpoteesi, et RSP-d liiguvad läbi membraani 
hõredamalt pakitud membraanipiirkondade kaudu. Lisaks kolesteroolile modu-
leerib plasmamembraanis paiknev tseramiid membraani struktuuri ja omadusi, 
mõjutades sealhulgas ka membraani kõverust ja moodustades plasmamemb-
raanis tihedalt pakitud tseramiidi parvesid. Sellest tulenevalt uuriti, kas taolised 
lipiidide ümberkorraldused võivad mõjutada RSP-de penetratsiooni PMV-desse. 
Selgus, et arginiinirikkad RSP-d (Arg9 ja pTat) olid võimelised tseramiidirikast 
membraani läbima paremini, kuid amfipaatsete RSP-de (TP ja TP10) penetrat-
sioon vesiikulitesse oli tugevalt takistatud. Varasemalt on näidatud, et tseramiid 
põhjustab membraani kõverdumist sissepoole ja see võis soodustada arginiini-
rikaste RSP-de sisenemist vesiikulitesse. Kuna amfipaatsed peptiidid vajavad 
membraani läbimiseks rohkem dünaamilisi membraani piirkondi, siis arvata-
vasti takistas nende RSP-de sisenemist vesiikulitesse eelkõige tseramiidi võime 
moodustada membraanis korrastatud lipiidifaase. Hiljuti näidati, et ka valgud 
osalevad plasmamembraani lipiidifaaside organiseerimises, mistõttu uuriti val-
kude osalust RSP-de sisenemises vesiikulitesse. Meie tulemused näitasid, et 
arginiinirikkad RSP-d vajavad membraani läbimiseks valke, mis võivad olla kas 
peptiididele retseptoriks või siis moduleerivad valgud vesiikulite membraanide 
omadusi hõlbustades penetreerumist. Samas selgus, et amfipaatsed RSP-d memb-
raani läbimiseks valgulist komponenti ei vaja. Viimasena hinnati rakuvälise 
maatriksi polüsahhariidide – glükoosaminoglükaanide osalust RSP-de trans-
lokatsioonis läbi membraani PMV-desse. Kuna glükoosaminoglükaanid on nega-
tiivselt laetud, siis arvatavasti on need esimesed plasmamembraani komponendid, 
millega katioonsed RSP-d interakteeruvad. Tulemused näitasid, et vastupidiselt 
eeldatule on glükoosaminoglükaanid olulised amfipaatsete peptiidide membraani 
läbimisel, kuid arginiinirikaste RSP-de penetratsioon toimub tõenäoliselt plasma-
membraani polüsahhariididest sõltumatult. Seda kinnitab ka tulemus, et memb-
raani korrastumata faasi, kuhu seonduvad amfipaatsed RSP-d, koondusid ka 
glükoosaminoglükaanid. Lisaks olid amfipaatsed RSP-d võimelised vesiikulite 
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membraani ümber korraldama, koondades need polüsahhariidid lipiidsetesse 
parvedesse. 
Kokkuvõtvalt kinnitas käesolev töö, et uuritud RSP-d suudavad raku-
energiast sõltumatut mehhanismi kasutades läbida plasmamembraani ilma selle 
barjäärifunktsiooni kahjustamata ning nende sisenemine ja interaktsioonid 
membraani erinevate komponentidega sõltuvad peptiidide füüsikalis-keemilistest 
omadustest. Selle põhjal jagunesid uuritud peptiidid kahte klassi: arginiinirikkad 
RSP-d, mille translokatsioonis osalevad membraani pinna valgud ning nende 
membraani läbimise efektiivsus suureneb membraanis tseramiidi olemasolul. 
Amfipaatsete peptiidide translokatsioon seevastu toimub membraani hõredamalt 
pakitud regioonidest ja kaasab glükoosaminoglükaanid. 
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